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 ABSTRACT 
 
 
The role of the immune system is to protect an organism against pathogens while 
maintaining tolerance against self. T cells are an essential component of the immune 
system and they develop in the thymus. The AIRE (autoimmune regulator) gene 
product plays an important role in T cell development, as it promotes expression of 
peripheral tissue antigens in the thymus. Developing T cells, thymocytes, which 
recognize self-antigens with high affinity are deleted. However, this deletion process 
is not perfect and not all autoreactive T cells are destroyed. When the distinction 
between self and non-self fails, tolerance breaks and the immune system attacks the 
host’s own tissues. This results in autoimmunity.  
Regulatory T cells contribute to the maintenance of self-tolerance. They can 
actively suppress the function of autoreactive cells. Several populations of cells with 
regulatory properties have been described, but the best characterized population is the 
natural regulatory T cells (Treg cells), which develop in the thymus and express the 
transcription factor FOXP3. The thymic development of Treg cells in humans is the 
subject of this thesis.  
Thymocytes at different developmental stages were analyzed using flow 
cytometry. The CD4-CD8- double-negative (DN) thymocytes are the earliest T cell 
precursors in the T cell lineage. My results show that the Treg cell marker FOXP3 is 
up-regulated already in a subset of these DN thymocytes. FOXP3+ cells were also 
found among the more mature CD4+CD8+ double-positive (DP) cells and among the 
CD4+ and CD8+ single-positive (SP) thymocytes. The different developmental stages 
of the FOXP3+ thymocytes were isolated and their gene expression examined by 
quantitative PCR. T cell receptor (TCR) repertoire analysis was used to compare these 
different thymocyte populations. My data show that in humans commitment to the 
Treg cell lineage is an early event and suggest that the development of Treg cells 
follows a linear developmental pathway, FOXP3+ DN precursors evolving through 
the DP stage to become mature CD4+ Treg cells.  
Most T cells have only one kind of TCR on their cell surface, but a small 
fraction of cells expresses two different TCRs. My results show that the expression of 
two different TCRs is enriched among Treg cells. Furthermore, both receptors were 
capable of transmitting signals when bound by a ligand. By extrapolating flow 
cytometric data, it was estimated that the majority of peripheral blood Treg cells are 
indeed dual-specific. The high frequency of dual-specific cells among human Treg 
cells suggests that dual-specificity has a role in directing these cells to the Treg cell 
lineage.  
It is known that both genetic predisposition and environmental factors 
influence the development of autoimmunity. It is also known that the dysfunction or 
absence of Treg cells leads to the development of autoimmune manifestations. 
APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy) is a 
rare monogenic autoimmune disease, caused by mutations in the AIRE gene. In the 
absence of AIRE gene product, deletion of self-specific T cells is presumably 
disturbed and autoreactive T cells escape to the periphery.  I examined whether Treg 
cells are also affected in APECED.  
I found that the frequency of FOXP3+ Treg cells and the level of FOXP3 
expression were significantly lower in APECED patients than in controls. 
Additionally, when studied in cell cultures, the suppressive capacity of the patients’ 
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 Treg cells was impaired. Additionally, repertoire analysis showed that the TCR 
repertoire of Treg cells was altered. These results suggest that AIRE contributes to the 
development of Treg cells in humans and the selection of Treg cells is impaired in 
APECED patients.  
In conclusion, my thesis elucidates the developmental pathway of Treg cells in 
humans. The differentiation of Tregs begins early during thymic development and 
both the cells’dual-specificity and AIRE probably affect the final commitment of Treg 
cells.  
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 TIIVISTELMÄ  
 
 
Immuunijärjestelmä suojaa kehoa hyökkäämällä tunnistamiaan taudinaiheuttajia 
vastaan. Immuunipuolustuksessa keskeiset T-solut kehittyvät kateenkorvassa. 
Kehityksen aikana sellaiset solut, jotka tunnistavat omia antigeenejä liian 
voimakkaasti tuhotaan. Tätä kutsutaan immunologiseksi toleranssiksi.  Virheellisten, 
autoreaktiivisten T-solujen poistamista tehostaa AIRE-geeni (autoimmune regulator). 
Autoreaktiivisia soluja saattaa kuitenkin päästä elimistöön, jolloin ne voivat aiheuttaa 
autoimmuunitauteja. T-solujen toimintaa omaa elimistöä vastaan voivat estää 
säätelijä- eli regulatoriset T-solut (Treg-solut). Tämä väitöskirjatutkimus selvittää 
Treg-solujen kehitystä ihmisessä.  
Useita säätelijäsolupopulaatioita on kuvattu, mutta parhaiten tunnetaan 
FOXP3-transkriptiotekijää ilmentävät Treg-solut. Analysoin varhaisia T-solujen 
esiasteita eli tymosyyttejä eri kehitysvaiheissa virtaussytometriaa käyttäen. Varhaisin 
T-solulinjan solu on CD4-CD8- (DN, double-negative) solu. Jo osa näistä varhaisista 
DN-soluista ilmentää FOXP3-geeniä. FOXP3+ soluja oli nähtävissä myös 
kypsemmissä tymosyyteissä. Eristin eri kehitysvaiheissa olevia tymosyyttejä ja tutkin 
eri geenien ekspressiota kvantitatiivisen PCR:n avulla. Lisäksi tarkastelin 
tymosyyttipopulaatioita vertailemalla niiden T-solureseptorirepertuaareja.  Tulokseni 
viittaavat siihen, että ihmisen Treg-solut eriytyvät omalle kehityslinjalleen jo hyvin 
varhaisessa vaiheessa ja kehitys etenee samaan tapaan kuin tavallisillakin T-soluilla.  
Valtaosalla T-soluista on pinnallaan vain yhdenlaisia T-solureseptoreja. 
Tutkiessani FOXP3+ tymosyyttejä, Treg-solujen esiasteiden geeniekspressio viittasi 
siihen, että niillä saattaisi olla muita soluja useammin kaksi eri T-solureseptoria 
pinnallaan. Lisätutkimukset osoittivat havainnon pitävän paikkaansa. Molemmat T-
solureseptorit pystyivät myös välittämään signaaleja solun sisään, kun T-
solureseptoria stimuloitiin. Virtaussytometriatulosten perusteella arvioimme, että 
valtaosa verenkierrossa olevista Treg-soluista ekspressoi pinnallaan kahta erilaista T-
solureseptoria. Koska solujen määrä on näin suuri, vaikuttaa tämä ominaisuus 
todennäköisesti Treg-solujen kehitykseen kateenkorvassa.  
Autoimmuunitautien syntymekanismeja ei tunneta tarkasti, mutta tiedetään, 
että sekä ympäristötekijöillä että geenivirheillä on vaikutusta. Lisäksi on todettu, että 
regulatoristen T-solujen toiminnan poikkeavuudet ovat ainakin osatekijä useissa 
autoimmuunisairauksissa. APECED (Autoimmuunipolyendokrinopatia-kandidiaasi-
ektodermaalinen dystrofia) on autoimmuunisairaus, jonka tiedetään olevan 
harvinainen yhden geenin mutaation aiheuttama tauti. Mutaatio on paikallistettu 
AIRE-geeniin. Mutaation seurauksena autoreaktiivisten T-solujen tuhoaminen 
todennäköisesti häiriintyy. Koska Treg-solut ovat tärkeitä immunologisen toleranssin 
säilyttämisessä, tässä väitöskirjatutkimuksessa tutkittiin myös niiden toimintaa 
autoimmuunitaudissa, APECEDissa.  
APECED-potilaiden Treg-solujen analysointi osoitti, että potilailla on 
huomattavasti vähemmän FOXP3+ -Treg soluja ja näissä soluissa FOXP3-ekspression 
määrä on matalampi kuin verrokeissa. Lisäksi soluviljelmät osoittivat, että APECED-
potilaiden Treg-solujen kyky estää muiden solujen jakaantumista oli heikentynyt. T-
solureseptorirepertuaarianalyysi osoitti myös, että APECED-potilaiden Treg-solujen 
T-solureseptorit eroavat verrokkien Treg-solujen T-solureseptoreista. Tulokset 
osoittavat, että AIRE:n puuttuessa Treg solujen kehitys on häiriintynyt APECED-
potilailla.  
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 Väitöskirjatutkimukseni tulokset antavat uutta tietoa Treg-solujen kehityksestä 
ihmisen kateenkorvassa. Treg-solujen erilaistuminen alkaa hyvin varhaisessa 
vaiheessa, ja AIRE-geeni sekä kahden eri T-solureseptorin pintaekspressio vaikuttavat 
niiden kehitykseen. 
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 ABBREVIATIONS 
 
AIRE    autoimmune regulator 
APC    antigen presenting cell 
APECED Autoimmune-Polyendocrinopathy-Candidiasis-Ectodermal 
dystrophy 
CDR    complementarity determining region  
cTEC   cortical thymic epitehelial cell 
CTLA-4   cytotoxic T lymphocyte antigen 4  
DC    dendritic cell 
DN    double-negative CD4-CD8- thymocyte 
DP    double-positive CD4+CD8+ thymocyte 
eTAC    extrathymic Aire-expressing cells 
ETP    early thymic progenitor 
FACS   fluorescence-activated cell sorting 
FOXP3  forkhead box P3 
c    common  chain 
GFP    green fluorescent protein 
GITR   glucocorticoid-induced tumor necrosis factor receptor 
HLA    human leukocyte antigen 
HSC    hematopoietic stem cells 
IDO    indoleamine 2,3-dioxygenase  
IFN-   interferon alpha 
IFN-   interferon gamma  
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 IPEX Immunodysregulation, Polyendocrinopathy, Enteropathy, X-
linked 
ISP immature single-positive 
ITAM    immunoreceptor tyrosine-based activation motifs 
LAG3    lymphocyte activation gene 3 
LT-    lymphotoxin alpha 
mAb    monoclonal antibody  
MFI   mean fluorescence intensity 
MHC    major histocompatibility complex  
mRNA   messenger ribonucleic acid 
miRNA   microRNA 
mTEC    medullary thymic epithelial cells 
NFAT    nuclear factor of activated T-cells 
NFB   nuclear factor kappa-light-chain-enhancer of activated B cells 
NOD   non-obese diabetic  
PBL   peripheral blood lymphocyte 
PBMC   peripheral blood mononuclear cells  
PCR   polymerase chain reaction 
PTA    peripheral tissue-antigens 
pT    pre T cell receptor  chain 
RAG 1&2  recombination activating genes 1&2 
SP    single positive CD4+ or CD8+ thymocyte 
TAP    transporter associated with antigen processing  
TCR    T cell receptor  
TEC    thymic epithelial cell 
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 Th1    T helper 1 cell 
Th2   T helper 2 cell 
Th17    T helper 17 cell 
TNF-   tumor necrosis factor alpha 
TREC    T cell receptor excision circle  
Treg cell   regulatory T cell 
TSLP    thymic stromal lymphopoietin 
TSP    thymus seeding progenitor 
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REVIEW OF THE LITERATURE 
 
1 T CELL SUBSETS 
 
T lymphocytes or T cells are a central component of cell-mediated immunity. The T 
cells compose the adaptive immune system in conjunction with the B cells. The T 
cells recognize their specific antigens through a T cell receptor (TCR). The majority 
of the T cells express an accessory molecule on their cell surface, either CD4 or CD8. 
The T cells are divided into two main subsets according to the expression of these 
molecules: The CD4+ T cells recognize antigens presented by antigen presenting cells 
(APC) expressing major histocompatibility complex (MHC) class II molecules, while 
the CD8+ T cells recognize antigens in MHC class I molecules (Andersen et al. 2006). 
These molecules are discussed in depth later. 
 
1.1 CD8+ T cells 
Upon activation, the CD8+ T cells differentiate into CD8+ cytotoxic T cells, which kill 
their target cells by inducing apoptosis. The CD8+ T cells are particularly important in 
immunologic defense against viral infections, and also against other intracellular 
pathogens. Further, they recognize dysfunctional or malignant host cells. The 
elimination of infected or dysfunctional cells without damaging the healthy tissue 
requires that the cytotoxic mechanisms are targeted accurately. The CD8+ T cells can 
be activated directly by dendritic cells (DC). Usually, however, additional assistance 
is required. It is provided by the CD4+ T cells, which recognize related antigens on 
the surface of the same APC (Janeway et al. 2008) 
The CD8+ T cells utilize two different mechanisms in mediating the apoptosis, 
both require direct cell-to-cell contact. Once the cytotoxic T lymphocyte has 
recognized its antigen on the surface of the target cell, it releases cytotoxic granules 
into the intercellular space. The cytotoxic granules contain cytotoxins: perforin, 
granzymes, and in humans, granulysin. Perforin acts in the delivery of the contents of 
the granules through the target cell membrane, and thereupon the granzyme molecules 
released from the granules to the cytosol trigger the apoptosis by activating the 
caspase pathway. Granulysin has antimicrobial effects and can induce apoptosis. 
Another mechanism by which the CD8+ T cells can induce apoptosis is Fas-
mediated killing. The CD8+ T cells have a Fas ligand (CD95L or CD178) on their cell 
surface. When it binds to the Fas molecule (CD95) on the target cell, apoptosis is 
induced (Andersen et al. 2006, Harty et al. 2000). The third mechanism by which the 
cytotoxic T cells are known to act is through cytokines, for example interferon-
IFN-, tumor necrosis factor- (TNF- and lymphotoxin- (LT-. The IFN- 
enhances the expression of MHC class I molecules and other proteins involved in the 
peptide loading of the MHC class I molecules. Consequently, the presentation of 
endogenous peptides increases, as well as the chance that infected cells will be 
recognized. TNF- and LT- induce apoptosis through TNF receptor I (TNFR-I). 
They also act synergistically with the IFN- in activating macrophages. The IFN- 
also inhibits viral replication and viruses can thus be removed so that the infected cell 
survives (Harty et al. 2000). 
 15
   
1.2 CD4+ T cells 
The majority of the CD4+ T lymphocytes function as helper T cells. The CD4+ T cell 
population also includes the subset of regulatory T cells (Treg cells) (Sakaguchi et al. 
2008). The most important function of the activated CD4+ T cells is to activate and 
control the immune response and the cells taking part in it. The CD4+ T cells 
influence other immune cells, both with molecules on the cell surface and by 
secreting cytokines. For example, the interaction of the co-stimulatory molecule 
CD40L (CD154) on a CD4 T cell with CD40 on the APC activates the APC and 
induces diverse downstream effects depending on the target cell type (Jiang and 
Chess 2006).  
After activation, the CD4+ T cell population can be separated to various 
subsets. The fate of the progeny of a naïve CD4+ T cell is largely regulated by signals 
provided by the local cytokine milieu. Each naïve CD4+ T cell has the potential to 
differentiate to any of the T helper subsets and the pathway to which they commit 
depends on the signals received during activation. Activation of the transcription 
factor of a certain subset confirms the differentiation to that lineage. Activated 
effector T cells provide feedback and reinforce the priming of naïve T cells. 
Cytokines produced by a given T cell subset function as inducers of that subset and 
inhibit the differentiation of other subsets. The variety of cytokines affects 
substantially the incipient immune response as a whole (Janeway et al. 2008, Weaver 
et al. 2006). 
 
1.2.1 Th1 Cells 
The differentiation to T helper 1 (Th1) cells is favored when macrophages, DCs and 
NK cells secrete IFN- and IL-12. These cytokines induce expression of the 
transcription factor T-bet (Szabo et al. 2000), which is an essential regulator of Th1 
commitment. Activation of T-bet in turn triggers IFN- production and expression of 
IL-12 receptor 2 subunit, both further directing the cell to the Th1 lineage. Th1 cells 
participate in defence against intracellular pathogens, particularly viruses. They 
activate especially macrophages, NK cells and CD8+ T cells. In addition, Th1 
cytokines help to activate B cells and, in humans, transmit signals for 
immunoglobulin class switching to IgG1 and IgG3, which opsonize pathogens (Zhu 
and Paul 2008, Kondo and Martin 2001).  
 
1.2.2 Th2 cells 
The Th2 cells contribute to humoral immunity by activating B lymphocytes. They 
take part in the extermination of parasites and extracellular bacteria. The Th2 cells 
develop when the predominant cytokine is IL-4. The initial source of IL-4 is still 
unclear, but once the effector Th2 cells are generated, they promote the differentiation 
to the Th2 lineage by secreting IL-4 themselves. Consequent signaling leads to the 
activation of the transcription factor GATA-3 (Ouyang et al. 2000) in the T cell and 
production of cytokines IL-4, IL-5, IL-10 and IL-13. The Th2 cells induce 
immunoglobulin class switching, particularly to IgG2 and IgG4, and in addition 
conversion to IgE and IgA. Production of eosinophils and mast cells is also increased 
(Zhu and Paul 2008, Kondo and Martin 2001).  
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 1.2.3 Th17 cells 
The most recently discovered Th cell subset is the Th17 cells. Cytokines inducing the 
differentiation to Th17 cells are IL-6 and TGF- in mice (Stockinger et al. 2007), and 
in humans the crucial cytokines seem to be IL-6 and IL-1 (Acosta-Rodriguez et al. 
2007). Also IL-23 appears to be important for Th17 cell development and expansion, 
but it is not required for the Th17 commitment. The key regulator of Th17 
development is RORt (Ivanov et al. 2006) and a characteristic of these cells is the 
abundant production of cytokines belonging to the IL-17 family, hence the name 
Th17. The Th17 cells act against extracellular pathogens and they appear to boost the 
acute inflammatory response of innate immunity. They induce epithelial surfaces or 
fibroblasts, epithelial cells and keratinocytes to secrete molecules to recruit 
neutrophils and augment the production of neutrophils and macrophages from the 
bone marrow (Korn et al. 2009).  
 
1.2.4 Natural Treg cells 
There are also several subsets of T cells with suppressive capacity. These are called 
regulatory T cells (Roncarolo and Levings 2000). The best-known population is the 
CD4+ CD25+ natural regulatory T cells (Sakaguchi et al. 1995a, Baecher-Allan et al. 
2001, Stephens et al. 2001), which express the transcription factor forkhead box P3 
(FOXP3) (Fontenot and Rudensky 2005, Ziegler 2006). These cells commit to the 
regulatory phenotype during their development in the thymus. They are actively 
involved in maintaining immune tolerance (Sakaguchi et al. 2008). These cells are the 
focus of this thesis and are discussed in depth later. It has been reported that there are 
also thymus-derived CD8+CD25+FOXP3+ cells (Cosmi et al. 2003), but their 
significance in the periphery is still unknown. 
 
1.3 Other regulatory T cells 
In contrast to the natural FOXP3 expressing regulatory T cells, adaptive regulatory T 
cells develop from naïve CD4+ T cells in the periphery. Th3 cells are probably 
activated in the mucosa and they seem to control or suppress responses on the 
mucosal surfaces. Like Th2 cells, they produce IL-4 and IL-10, but they also secrete 
TGF-WeinerInobe  et al. Tr1 cells are induced in vitro when 
stimulated with high concentrations of IL-10. They produce IL-10 and TGF-, but to 
make a distinction with Th3, they do not secrete IL-4 (Groux et al. 1997). The activity 
of these cells is antigen-specific (Roncarolo and Levings 2000). Further, a population 
of induced regulatory T cells expressing FOXP3 has been described. FOXP3 is 
induced when naïve CD4+ T cell are under influence of TGF- instead of IFN-, IL-
12 or IL-4 (Chen et al. 2003, Kretschmer et al. 2005). Retinoic acid enhances the 
TGF- mediated induction of FOXP3 (Coombes et al. 2007, Sun et al. 2007). In mice 
these cells produce TGF- and have other suppressive mechanisms. Additionally 
antigen presentation under suboptimal conditions induces FOXP3+ suppressor cells 
(Kretschmer et al. 2005, Apostolou and von Boehmer 2004). The features of the 
regulatory populations may overlap and the distinction between different CD4+ Treg 
subsets is sometimes difficult (Shevach 2006).  
In addition there are some other T cell subpopulations which have been shown 
to have regulatory properties. NKT cells express both TCR and NK cell receptor. 
Their TCR repertoire diversity is limited, a part of them expressing the invariant 
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 V24J18/V11 TCR. They recognize lipids and glycolipids presented by CD1d 
molecules. Upon activation, they produce large quantities of cytokines (IL-4, INF-, 
TNF) and they also exhibit cytolytic activity (FasL, perforin). Deficiency or 
dysfunction of NKT cells is reported to cause autoimmune manifestations. 
Additionally they seem to have a role in tumor surveillance and infectious diseases 
(Roncarolo and Levings 2000, Bendelac et al. 2007). 
 T cells comprise less than 5 % of peripheral blood T cells, but they are 
enriched in epithelia. As  T cells do not require MHC molecules for antigen 
recognition, they do not usually express CD4 or CD8 co-receptors either. The 
antigens they recognize are poorly known, but they include pathogen-derived antigens 
and self-antigens up-regulated on stressed cells.  T cells have many effector 
functions and they are suggested to stand at the border between innate and adaptive 
immunity. They are thought to have an activating role and capability to elicit a rapid 
response in the beginning of immune reaction, especially in the vicinity of epithelia 
(gut, skin). On the other hand a regulatory role in modulating the immune responses 
has also been suggested for  T cells (Carding and Egan 2002). 
 Some peripheral CD8+ and CD4-CD8- double-negative (DN) cells have also 
been reported to have regulatory properties (Roncarolo and Levings 2000, Shevach 
2006, Strober et al. 1996). 
 
 
2 ANTIGEN RECOGNITION AND T CELL ACTIVATION 
2.1 T cell receptor complex 
The antigen recognition of the T lymphocytes occurs through the T cell receptor 
(TCR). TCR is a heterodimeric surface protein consisting of  and  chains. This is 
the case in 95 % of T cells. The residual 5 % bear alternative polypeptide chains, 
designated  and . Each glycoprotein chain of TCR is composed of variable (V) and 
constant (C) domains. The outer V domains of  and  chains form the antigen 
binding sites, the complementarity determining regions (CDR). CDR 1 and 2 bind the 
MHC molecule and CDR 3 is the antigen-binding site. In both chains there is also a 
transmembrane domain spanning the lipid bilayer, and a short cytoplasmic tail (Moss 
et al. 1992).  
The cytoplasmic tail of the receptor is too short to transmit signals inside the 
cell. Hence TCR is always expressed on the T cell membrane with the CD3 molecule. 
CD3 is a signal transduction complex composed of various chains and it enables T 
cell activation after its TCR has encountered an antigen. The cell-surface receptor 
complex is also associated with a homodimer of intracytoplasmic -chains, which 
signal to the interior of the cell upon antigen binding. The intracytoplasmic parts of 
the CD3 complex and -chains contain the immunoreceptor tyrosine-based activation 
motifs (ITAMs), and the phosphorylation of the tyrosines in the ITAMs serves as the 
first intracellular signal indicating that the lymphocyte has detected its specific 
antigen. The phosphorylated ITAMs engage ZAP70, the activation of which starts a 
pathway that eventually conducts signals from the cell membrane to the nucleus 
(Smith-Garvin et al. 2009).  
 The receptor structure of the  TCR is similar to the  receptor and it is also 
associated with CD3. In spite of the structural similarities of the  and the  TCRs, 
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 antigen recognition between these receptors differs remarkably (Carding and Egan 
2002, Moss et al. 1992). 
 
2.2 Antigen recognition by T cells 
In most cases, the  TCR recognizes antigens only when peptides are bound to 
MHC molecules. In humans, the MHC molecules are also called human leukocyte 
antigens (HLA). The MHC molecules are on the cell surface of the APCs, therefore 
cell to cell contact is required when  T cells recognize antigens. During antigen 
recognition, the T cell receptor makes contact with both the MHC molecule and the 
antigen peptide and therefore the T cell responses are called MHC restricted (Moss et 
al. 1992).  
There are two classes of MHC molecules, MHC class I and MHC class II. The 
MHC class I molecule is a heterodimer. Nearly all nucleated cells express MHC class 
I molecules. It consists of a membrane spanning  chain, which is composed of three 
domains (1-3) and which is non-covalently associated with 2-microglobulin. The 
peptide-binding cleft is formed on the surface of the molecule by 1 and 2 domains.  
The MHC class II molecule consists of two transmembrane proteins, the  and 
 chains and the peptide-binding cleft is thus formed by two different chains. It is 
expressed only on the cell surface of specialized APCs i.e. dendritic cells, 
macrophages, B lymphocytes and thymic epithelial cells (Rudolph et al. 2006).  
The three-dimensional structure of both the MHC classes is very similar. The 
major difference is that the peptide-binding cleft of the MHC class II molecule is 
more open. Hence, the ends of a peptide in the MHC class I are substantially 
embedded within the molecule, whereas in the MHC class II they are not. 
Consequently, the MHC class II molecules can bind longer peptides. The MHC 
molecules are very unstable when peptides are not bound. Peptide is bound as an 
integral part of the MHC molecule’s structure and the binding is solid. The MHC 
molecules are exceedingly polymorphic, with major differences in the peptide-
binding cleft. Each molecule can bind stably many different peptides. Genetic 
variation influences the repertoire of the antigens presented to T cells (Rudolph et al. 
2006).  
Antigens presented in the MHC class I molecules are typically synthesized 
inside the presenting cell itself. They are derived from intracellular proteins, which 
are degraded in the cytosol by proteasomes and transported through the transporter 
associated with antigen processing (TAP1&2) in the endoplasmic reticulum. 
Thereafter the antigen peptide binds the MHC molecule and the complex is 
transported to the cell surface. Class I molecules can signal to T cells that there is an 
intracellular infection, and recognition of foreign antigens associated to the MHC 
class I molecules leads to the killing of the presenting cell (Andersen et al. 2006, 
Germain and Margulies 1993). Additionally, DCs can process exogenous antigens 
into MHC class I molecules and present them to the cytotoxic CD8+ lymphocytes. 
This is referred to as cross-presentation. This is an important mechanism for 
generating immunity against viruses, for example in viral infections of the epithelial 
cells. Cross-presentation is also associated with tolerance induction (Bevan 1975, 
Bevan 2006, Heath and Carbone 2001). 
 The antigens presented in the MHC class II molecules originate from outside 
the cell. Endosomes containing extracellular antigens fuse with the vesicles 
containing the MHC class II molecules. The MHC class II associated invariant chain 
directs the newly synthesized MHC class II molecules to these acidified intracellular 
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 vesicles. Additionally the invariant chain prevents the MHC class II molecules from 
binding prematurely to the cell’s own peptides, or the peptides transported into the 
endoplasmic reticulum, and thus allows the MHC class II molecules to bind only 
peptides degraded in endosomes. The resulting peptide-MHC class II complex 
proceeds to the cell surface (Germain and Margulies 1993). 
 
2.3 Co-receptors  
In order to obtain an effective response during antigen recognition, accessory 
molecules CD4 or CD8 are associated on the T cell surface with the T cell receptor 
and bind nonpolymorphic sites on the MHC molecules. The intracellular parts of co-
receptors strengthen the signalling of the TCR-CD3 complex, thus the sensitivity of a 
T cell to the antigen presented is markedly increased.  
CD4 is a monomeric transmembrane protein composed of four 
immunoglobulin-like domains (D1-D4). It binds the MHC class II molecules during 
antigen recognition and this occurs mainly through a region located on the outermost 
first domain, D1.  
CD8 molecules combine with the MHC class I molecules. The CD8 is a dimer 
consisting usually of a pair of  and  chains, both members of the immunoglobulin 
superfamily. The CD8 chains can also form homodimers when the CD8 is not 
present. These homodimers may have a function in recognizing the nonclassical MHC 
class I molecules. The CD8 domain binds weakly to the 3 portion of the Class I 
MHC molecule (Janeway et al. 2008).  
Associated with the cytoplasmic domain of the CD4 and CD8 is the Lck 
tyrosine kinase which helps to activate the T cell, ZAP70 being one of the prime 
targets. The CD4 molecules bind significantly more Lck than the CD8 molecule, 
producing stronger signals. Ultimately, transcription factors, for example the nuclear 
factor of activated T cells (NFAT), activator protein 1 (AP-1) and nuclear factor 
kappa-light-chain-enhancer of the activated B cells (NFB) family members, are 
activated leading to initiation of the genetic program for T cell activation (Smith-
Garvin et al. 2009).  
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 2.4 T cell activation 
2.4.1 First signal 
Activation of a resting T cell during the immune response requires contact between 
the T cell and APC presenting foreign peptide/MHC complex with sufficient affinity. 
The activation occurs in lymph nodes or in other organized lymphoid tissues (Tseng 
and Dustin 2002). 
 
2.4.2 Second signal 
When a naïve T cell recognizes its specific ligand on APC, a conformational change 
occurs on cell-adhesion molecules and causes cells to bind with higher affinity to each 
other. To trigger an effective response to the antigen presented, the resting T cells 
need also other co-stimulatory signals besides the CD4/CD8 engagement with the 
TCR-MHC complex. To ensure that activation occurs only in appropriate situations, 
only professional APCs can give these additional signals. The most important co-
stimulatory receptor in T lymphocytes is CD28. Its ligands on the APC surface are 
B7-1 (CD80) and B7-2 (CD86). The B7 molecules are found only on the surface of 
cells that can stimulate the T cell proliferation. Co-stimulation must be delivered by 
the same APC on which the T cell recognizes its antigen. The CD8+ T cells seem to 
require stronger co-stimulatory signals than the CD4+ T cells (Andersen et al. 2006, 
Janeway et al. 2008). 
 
2.4.3 Third signal  
The additional signals that are required during activation are transmitted by cytokines, 
which strengthen and guide the response. The nature of the pathogen contributes to 
the outcome of what kinds of cytokines are secreted by the APCs. For example, the 
IL-12, IL-18 and IFN-are secreted by the DCs and macrophages in response to viral 
infections and direct the T cells towards cell-mediated immunity, whereas IL-4 guides 
towards humoral immunity. After induction, the T cells themselves start to secrete 
cytokines as well, thus further reinforcing the immune response. 
 
2.4.4 Consequences of activation 
Upon activation, the T cell proliferates and differentiates into an effector T cell. The 
effector T cells are capable of synthesizing all the molecules required for exerting 
their specialized functions. Once activated, the effector T cells do not require co-
stimulation to act (Janeway et al. 2008). 
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Figure 1. Interaction between T cell and dendritic cell 
 
Antigen recognition by T lymphocytes occurs through the TCR, which on the cell surface is 
always expressed with the CD3 molecule. The  T cells recognize antigens bound to the 
MHC molecules. The accessory molecule CD4 associates with the TCR-CD3 complex and 
binds to a MHC class II molecule while the CD8 binds to a MHC I molecule. The co-
receptors CD4 and CD8 strengthen the signaling of the TCR-CD3 complex. Effective 
activation of a naïve T cell requires also a second signal, which must be delivered by the same 
APC. The most important co-stimulatory molecule on T cells is CD28. Its ligands on the APC 
are CD80 (B7-1) and CD86 (B7-2). Effective activation happens only if the APC presents 
both the specific antigen and a B7 molecule. Activation of the T cell is also controlled by 
cytokines secreted by the APC.  
 
3 T CELL DEVELOPMENT AND CENTRAL TOLERANCE 
3.1 Thymus structure  
The development of T cells occurs in the thymus via a series of intermediate stages. 
The thymic stroma develops early during the embryonic development from the 
endodermal layer. The contribution of the ectodermal epithelium to the development 
of thymus is ambiguous (Rodewald 2008). The thymus consists of numerous lobules, 
each of which comprises a medulla and a cortex. Thymic epithelial cells (TECs) can 
be characterized by their expression of keratin. The TECs of the cortex and the 
medulla are functionally and phenotypically different, supporting different stages of T 
cell maturation. Most of the T cell development occurs in the cortex, thus the bulk of 
the immature thymocytes are within the cortex and thymocytes enter the medulla only 
after they are single-positive. The network of medullary TECs (mTECs) is compact, 
with the mature thymocytes interspersed within it (Chidgey et al.). The thymic 
medulla of humans also contains enigmatic structures called Hassall’s corpuscles, 
characterized by keratinized epithelial cells (Lobach et al. 1985). In addition to the 
maturing T cells or thymocytes and a network of epithelial cells, the thymus consists 
of intrathymic DCs, macrophages and B cells. Interactions between the thymic stroma 
and differentiating thymocytes are fundamental to the development of T cells. 
Moreover, lymphostromal interactions are required to maintain the functional 
potential of the stromal compartment (Janeway et al. 2008, Chidgey et al., Klaus 
2001). 
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Figure 2. Thymic Structure 
 
A. The thymus consists of several lobules separated by connective tissue septae. Each lobule 
consists of a cortex and a medulla. The cortex is rich in immature thymocytes (blue) and 
scattered cortical thymic epithelial cells (TECs; dark blue). Additionally, macrophages 
(yellow) are interspersed throughout the cortex. The macrophages eliminate apoptotic 
thymocytes. The medulla comprises numerous medullary TECs (purple) and mature 
thymocytes (blue). The macrophages and the thymic DCs (green) are also distributed 
throughout the medulla. Hassall’s corpuscles (pink), formed from keratinized epithelial cells, 
are also found in the medullary region. 
 Hematopoietic stem cells enter the thymus from the bloodstream at the cortico-
medullary junction. First, T cell precursors migrate to the subcapsular region of the thymic 
cortex. As the thymocytes mature, they migrate through the cortex towards the medulla and 
the most mature single-positive cells are found in the medulla. Positive selection of 
thymocytes occurs during the DP stage at the cortex and negative selection can occur at any 
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 time after the TCR is expressed on the cell surface, either in the cortex or in the medulla. The 
mature T cells leave the thymus and enter the bloodstream.  
B. Hematoxylin-eosin staining of thymic tissue. Connective tissue septae separate the 
different lobules. The cortical areas are darkly stained and the medulla is light. The large, 
pink structures in the medullary areas are Hassall’s corpuscles. 
 
3.2 Entry into thymus and early stages of T cell development 
T lymphocytes develop from hematopoietic stem cells (HSC) originated from the 
bone marrow. The HSCs differentiate to common lymphoid precursor cells (CLP) 
having the CD34+CD38- (CD45RA+) phenotype. The thymus seeding progenitor 
(TSP) enters the thymus and evolves into an early thymic progenitor (ETP). These 
CD34+CD38low cells form the most immature population in the thymus. It is known 
that at least part of the seeding precursor cells are still multipotential, being able to 
differentiate also to B cells, NK cells and DCs. This indicates that the T cell 
commitment takes place within the thymus (Blom and Spits 2006). The ETPs are 
CD1a-, and as the development proceeds, differentiating cells become CD34+CD1a+. 
CD1a is a useful marker for identification of immature thymocytes in humans and up-
regulation of CD1a marks T cell lineage commitment. The CD1a+ cells begin to 
undergo rearrangements in the TCR , , and  loci. At this stage, maturing 
thymocytes do not express either CD4 or CD8 and are called double-negative 
thymocytes (DN). Consecutive stages in the development are marked by changes in 
cell-surface molecules (Chidgey et al., Plum et al. 2008, Spits 2002).  
The transcription factor Notch is essential for the T cell lineage decision and 
development. IL-7 is also indispensable for T cell development. It is important for 
proliferation and survival of the early T cell precursors, as already ETPs express IL-
7RBlomandSpits. 

3.3 -rearrangements 
Rearrangements occur during early stages of T cell development in the order 
>>>, but almost simultaneously in the ,  and  loci. Here I concentrate on the 
 and  gene arrangements. As the most immature T cells are double-negative, the 
next stage consists of CD4 immature single positive (ISP) cells, which start to express 
also first the CD8 chain and thereafter the CD8 chain, developing to double-
positive (DP) CD4+CD8+ T cells. The rearrangement of the TCR -chain locus begins 
during these stages (Janeway et al. 2008, Spits 2002).  
The function of recombination activating genes (RAG1&2) is fundamental to 
the gene rearrangements (Sadofsky 2004). The first gene segments to be rearranged 
are D with J and this is succeeded by V rearranging with D-J. Diversity of the 
junctional regions is increased by adding P- and N-nucleotides. The junctional regions 
of the  and  chains are most variable. They contribute to CDR3s, which form the 
antigen binding site. If the thymocyte fails to make a successful -recombination, the 
cell dies, unless the  and  rearrangements take place and rescue the cell to continue 
development on the  T cell lineage (Chidgey et al., Spits 2002, Schatz et al. 1992).  
After productive, in-frame TCR rearrangements, the TCR protein pairs with a pre 
T cell receptor  chain (pT) and is expressed with the CD3 molecule on the cell 
surface. The PreTprotein belongs to the immunoglobulin superfamily. Its 
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 expression is developmentally regulated and restricted to lymphoid cells. Onset of the 
PreT expression precedes  chain rearrangements, and the transcription is highest in 
the CD4 ISP and CD4+CD8+ DP thymocytes (Ramiro et al. 1996, von Boehmer and 
Fehling 1997, Carrasco et al. 2002). 
Cells expressing the preTCR complex are selected for further differentiation. 
This -selection occurs in variable stages of the early T cell development where 
expression of the CD4 and CD8 differ. First cells express -chain even before the 
CD4 expression, and some cells start  rearrangements only when both the CD4 and 
CD8 are already expressed. The pre-T cell receptor signals to the cell to abort 
further  chain rearrangements (Spits 2002, von Boehmer et al. 1998). 
Before starting the rearrangements in  locus, the DP thymocytes proliferate 
intensely. The DP cells constitute the biggest thymocyte subset. DP thymocytes may 
also have an influence on early thymocyte precursors, thus contributing to the thymic 
crosstalk (Janeway et al. 2008, Spits 2002, Takahama 2006). 
 
 
 
 
 
Figure 3. Developmental stages of T cells in the human thymus 
 
Hematopoietic stem cells originate from the bone marrow and when they enter the thymus 
they are still multipotent. The next stage after the early thymic precursor cells (ETP) is 
already committed to the T cell lineage. After commitment to the T cell lineage, the double-
negative (DN) cells begin to rearrange their TCR , and loci. If the successful TCR  and 
 rearrangements occur prior to -selection, the cell will likely develop into a  T cell.  
The -selection and expression of the co-receptors, first CD4 and then CD8, begin at 
the same time. Recombination of the  chain occurs during the double-positive (DP) stage. 
Positive and negative selection may occur when the thymocyte expresses a functional  
TCR on the cell surface. The CD4/CD8 lineage choice is made during the positive selection. 
 
3.4 -rearrangements 
The TCR locus contains only V and J gene segments. The gene segments encoding 
the  chain are entirely within the TCR locus, hence any rearrangement in the  
locus causes the deletion of the  locus (Krangel et al. 1998). After the proliferative 
phase, the RAG-genes are again up-regulated in the DP thymocytes and the RAG 
proteins join V to J. Nucleotides are inserted in the V-J junctions of the  chains as 
well. Because of the numerous V and J segments, multiple sequential 
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 rearrangements can occur until the productive rearrangement takes place. Thus a 
developing T cell that already has a functional -chain can be rescued from cell death 
even when early -rearrangements fail. The -rearrangements continue until the self-
peptide:self-MHC complex induces the TCR transmitted signals through the  TCR, 
or the cell dies (Starr et al. 2003).  
 
 
 
 
 
Figure 4. TCR rearrangements 
 
Sequential gene rearrangements in the TCR  and  loci. The first gene segments to be 
arranged are D with J, followed by the joining of Vto DJ. The joining of the V, D and J 
segments involves the looping-out and deletion of the intervening DNA between the genes to 
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 be joined. Recombinations are carried out by the recombination activating gene (RAG) 1 and 
2 proteins. The genes are expressed in developing lymphocytes only when the TCRs are 
assembled. The rearrangements start in the DN stage (upper part of the figure). When 
successful rearrangements occur, the -chain is expressed on the cell surface with preTnot 
shown). This preTCR complex signals to stop further -chain rearrangements. The DP 
thymocytes proliferate before starting rearrangements in the  locus. The TCR  locus 
contains only V and J segments (the lower part of the figure). Additionally, the  locus is 
entirely within the TCR  locus, and any rearrangements in the  locus delete the  locus (not 
shown). Because of the large number of V and Jsegments, rearrangements in the  locus 
can proceed for several cycles. After a productive  rearrangement, the  and the  chain pair 
and they are expressed on the cell surface as  TCR. Nucleotides are inserted by the 
deoxynucleotidyl transferase (TdT) in the D-J, V-DJ and V-Jjunctions to increase 
the diversity of the TCR. 
 
3.5 Allelic exclusion  
Allelic exclusion is a process where protein from only one allele is expressed and the 
other allele is silenced (Malissen et al. 1992). In other words, when a functional  
chain is rearranged, it hinders further -chain gene recombination in the other locus. 
The  locus, instead, lacks allelic exclusion. Both alleles of the  chain gene 
simultaneously rearrange until the  chain pairs with the  chain and receptor 
engagement to self-peptide:self-MHC complex occurs (Borgulya et al. 1992). Positive 
selection switches off the RAG expression. That is, T cells can have many rearranged 
 chains from both chromosomes which are tested for self-peptide:self-MHC 
recognition. This, in turn, enables existence of T cells which express two different 
TCRs with the same  chains and different  chains (Casanova et al. 1991).  
 
3.6 Dual-specific T cells 
Lack of allelic exclusion in the  locus challenged the old view of one cell bearing 
only one receptor specificity. Although the frequency of two in-frame -
rearrangements is reported to be quite high, there are mechanisms limiting the 
frequency of two different  chains expressed on the cell surface. One factor limiting 
the surface expression is the preferential association of some  chains with the  
chain, others being unable to pair at all (Malissen et al. 1992, Kuida et al. 1991, 
Corthay et al. 2001). The post-translational mechanisms affecting the surface 
expression are called phenotypic allelic exclusion. Cells expressing two  chains are 
much more frequent in the developing TCRlow thymocytes, and it has been shown that 
the phenotypic allelic exclusion occurs quite simultaneously with positive selection. 
As dual-TCR cells are more prevalent among the resting population, the phenotypic 
allelic exclusion may be regulated by TCR signaling (Boyd et al. 1998, Gascoigne 
and Alam 1999, Niederberger et al. 2003). 
The mechanisms inhibiting the expression of two different TCRs on a cell 
surface are incomplete, and there is still a noticeable population of cells in the 
periphery that are dual-specific. It has been reported that up to 30 % of human or 
mouse peripheral T cells may express two TCR chains (Casanova et al. 1991, 
Padovan et al. 1993, Heath et al. 1995). It was originally thought that the second 
receptor would not function, as it has not been positively selected and therefore it 
would not recognize MHC molecules (Malissen et al. 1992, Corthay et al. 2001, Boyd 
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 et al. 1998, Niederberger et al. 2003, Heath et al. 1995, Gascoigne and Alam 1999, 
Lacorazza and Nikolich-Zugich 2004). However, the TCR chains are inherently 
biased towards MHC recognition (Zerrahn et al. 1997), so that even before the 
selection a large proportion of the TCRs may interact with the MHC and hence be 
functional. If the dual-specific T cell passes positive selection through one receptor, 
the other, unselected, receptor could potentially be autoreactive. The escape from 
negative selection may also be facilitated if the second receptor is expressed at low 
density (Zal et al. 1996). In the periphery, the dual-specific T cell may be activated 
through either of the receptors. In addition, mouse models have shown that the second 
(self-specific) receptor can function, even when the cell has been activated initially 
through the other receptor (Zal et al. 1996).  
Several studies have indeed addressed the role of dual-specific T cells in 
autoimmunity (Elliott and Altmann 1995, Sarukhan et al. 1998). In a TCR transgenic 
system the expression of a second TCR could save autoreactive T cells from deletion 
(Zal et al. 1996). Other studies, however, have demonstrated that the dual-specific 
cells do not increase susceptibility to autoimmunity and may even have a protective 
role (Corthay et al. 2001, Van de Keere and Tonegawa 1998, Olivares-Villagomez et 
al. 1998, Itoh et al. 1999, Kawahata et al. 2002, Hori et al. 2002). The studies of dual-
specific cells are based mainly on transgenic models, and the effects of dual-
specificity in normal immune system, if any, are unknown.  
 
3.7 Positive selection 
In order to mature as CD4 or CD8 single positive (SP) T lymphocytes, DP 
thymocytes have to receive adequate signals through their TCR. Several elegant 
experiments using mouse models have elucidated the selection process. As the 
antigen recognition of T cells is MHC restricted, the immature T cells must recognize 
self-MHC. Positive selection occurs in the cortex where the cortical TECs (cTECs) 
introduce self-peptide:self-MHC complexes to maturing thymocytes. Thus the MHC 
molecules expressed in the environment where T cells develop determine which MHC 
molecules the mature T cells recognize as self (Starr et al. 2003). The TCR V chain 
possibly has a more important role in the TCR-MHC interaction (Gascoigne and 
Alam 1999).  
The co-receptor expressed on a single-positive thymocyte is also defined in 
the course of or after positive selection. The decision of phenotype depends on which 
MHC molecule the TCR recognizes, MHC class I recognition leading to CD8 
expression and MHC class II to CD4 expression. How the TCR specificity dictates 
the CD4/CD8 choice has been difficult to resolve and is still under debate. It is 
unclear whether the decision is stochastic, or dependent on the strength or duration of 
TCR signaling. These propositions are however at least in part contradictory (Singer 
et al. 2008).  
At the moment the CD4/CD8 lineage choice is best explained by the kinetic 
signaling model, proposing that the TCR-signal duration, in concert with the 
cytokines of the common -chain receptor family, such as IL-7, determine the co-
receptor. According to this model, both the CD4 and CD8 committed cells down-
regulate the CD8 after positive selection. Should the positively selecting signals be 
MHC class II restricted, the TCR signaling persists in the CD4+CD8- cells. This in 
turn impairs the IL-7 signaling and induces the differentiation into a mature CD4+ T 
cell. However, if the positively selecting TCR signaling is MHC class I restricted, it is 
disrupted in the CD4+CD8- cells and the continuous IL-7 signaling enables co-
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 receptor reversal and differentiation into the CD8+ cells. The lineage decision must 
induce functional programming, so that different gene expression is induced for 
cytotoxic CD8+ cells and for cytokine producing CD4+ cells (Takahama 2006, Singer 
et al. 2008). CD69, a molecule associated with the TCR-mediated signaling, is up-
regulated after positive selection (Hare et al. 1999). 
 
3.8 Negative selection 
After being positively selected, the thymocytes migrate towards the thymic medulla. 
The TCR repertoire of the developing T cells has to be extensive. Recognition of vast 
amounts of foreign antigens is required, while recognition of self should be avoided. 
Thus the T cells with TCR specific to self-antigens must be destroyed. Developing 
cells are introduced to the MHC molecules complexed with self-peptides. Antigens 
are presented by DCs, macrophages and the specialized stromal cells known as 
mTECs. Because the DCs and the macrophages are able to activate mature T cells 
effectively in the periphery, they are presumably the most efficient mediators of 
negative selection also in the thymus.  
It is still uncertain what precisely mediates the balance between survival and 
cell death. There are currently two predominant hypotheses. The first model states 
that the selection is determined by the affinity of the TCR to peptide/MHC complex, 
providing different signal strengths intracellularly. This means that the binding of 
self-peptide:self-MHC with low affinity signals survival for thymocytes, while strong 
binding leads to apoptosis. The other model suggests that intracellular signals, 
generated during the binding of TCR to self-peptide-MHC complex, differ 
qualitatively during positive and negative selection. Negative selection may occur at 
any stage of thymic differentiation beginning at the double-positive stage where 
expression of the  TCR originates and extending to nearly mature SP  
thymocytes. The elimination of potentially self-reactive T cells during T cell 
development is referred to as central tolerance (Klaus 2001, Takahama 2006, Palmer 
2003) 
 
3.9 AIRE and central tolerance  
It has recently become clear that in order to facilitate negative selection, tissue-
specific antigens are actively transcribed in the thymus (Derbinski et al. 2001, Linsk 
et al. 1989) and presented by mTECs and DCs . This ectopic transcription is not fully 
understood, but one factor promoting it is a gene called AIRE (AutoImmune 
REgulator). The AIRE gene has the ability to induce the expression of an extensive 
selection of peripheral tissue-antigens (PTA), and in that way to contribute to negative 
selection of autoreactive thymocytes (Anderson et al. 2002, Liston et al. 2003). It has 
been estimated that the AIRE may influence the expression of several hundred, or 
more likely several thousand genes (Derbinski et al. 2005). However, it should be 
noted that, firstly, there is also AIRE-independent antigen presentation (Kuroda et al. 
2005, Niki et al. 2006) and consequently other genes or mechanisms also promote 
expression of PTAs and, secondly, AIRE has also other functions besides ectopic 
transcription (Mathis and Benoist 2009). 
Proper thymic microenvironment is required for AIRE expression. It has been 
reported that AIRE expression is decreased under conditions in which normal thymic 
architecture is disturbed (Zuklys et al. 2000). Additionally, AIRE itself seems to have 
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 a role in the differentiation of mTECs, and PTAs are expressed only in terminally 
differentiated mTECs (Hamazaki et al. 2007, Yano et al. 2008, Gray et al. 2007).  
 
 
 
 
 
Figure 5. Selection of developing thymocytes 
 
Maturing thymocytes have to receive adequate signals through their TCR to survive. If the 
TCR of the thymocyte does not recognize the self-MHC/self-peptide complex on the surface 
of a thymic antigen-presenting cell (APC), the thymocyte will die. This is referred to as death 
by neglect. 
 If the self-MHC/self-peptide complex is recognized with a low affinity, the 
thymocyte survives and the cell is positively selected. A high-affinity interaction with the 
self-MHC/self-peptide complex leads to negative selection of the developing thymocyte. It 
has also been suggested that the recognition of self antigen with intermediate to high affinity 
may promote generation of FOXP3+Treg cells. 
 In order to facilitate negative selection, peripheral tissue antigens are presented to the 
developing thymocytes in the thymic medulla by mTECs and dendritic cells. The 
transcription of these peripheral antigens is partly under the control of the transcription factor 
AIRE. 
 
 
4 DEVELOPMENT OF NATURAL REGULATORY T CELLS 
 
4.1 Identification of natural regulatory T cells 
Regulatory T cells (Treg cells) represent ~5-10 % of CD4+ cells in the periphery. The 
Treg cells actively maintain tolerance and immunologic homeostasis (Sakaguchi 
2004). Depletion of the Treg cells leads to severe immunological disturbances both in 
humans and mice (Sakaguchi 2004, Wraith et al. 2004). The existence and importance 
of these cells were questioned for a long time, but at present the significance of this 
population is undisputed.  
In mice, the Treg cell development is delayed compared to non-regulatory T 
cells during ontogeny and the Treg cells start to emerge only after birth. It was at first 
discovered that in mice, thymectomy on day three after birth led to severe 
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 autoimmune manifestations, which could be prevented by transfer of total 
lymphocytes or CD4+ lymphocytes (Nishizuka and Sakakura 1969, Sakaguchi et al. 
1982, Penhale et al. 1973, Penhale et al. 1975, Sakaguchi 2004). These observations 
demonstrated that autoreactive T cells exist in normal mice, and that there are cells 
capable of suppressing these pathogenic cells. After the discovery of CD25 as a 
specifying marker for these regulatory cells (Sakaguchi et al. 1995), more specific 
studies have confirmed this suppressive effect. The transfer of CD4+ T cells devoid of 
CD25+ cells produces autoimmune disease in athymic, T cell deficient nude mouse, 
while the co-transfer of CD25+CD4+ cells inhibits autoimmunity (Asano et al. 1996). 
In vitro assays have also demonstrated that the CD4+CD25+ cells co-cultured with 
CD4+CD25- are able to suppress the proliferation of the CD25- T cells (Thornton and 
Shevach 1998).  
In contrast, the human Treg cells are detected in the thymus already on week 
13 of gestation, simultaneously with conventional T cell subsets and a few weeks later 
also in the periphery (Darrasse-Jeze et al. 2005). The difference between mice and 
humans is probably explained by the substantially longer gestation of humans. 
Additionally, functional adaptive Treg cells can be induced already in the fetal 
periphery (Mold et al. 2008).  
 
4.2 FOXP3 gene 
4.2.1 Significance of FOXP3 to Treg cells 
The key marker for natural Treg cell population is the transcription factor forkhead 
box P3 (FOXP3) (Khattri et al. 2003, Fontenot et al. 2003) This gene is considered to 
be involved in the development of natural Treg cells, and is seen as essential for the 
function of these thymus-derived natural regulatory T cells. Continuous expression of 
the gene is required to maintain the differentiated phenotype (Williams and Rudensky 
2007, Lopes et al. 2007). Retroviral gene transfer of FoxP3 reprograms murine T cells 
to become Treg cells (Hori et al. 2003, Fontenot et al. 2003).  
Mutation of FOXP3 gene leads to a severe autoimmune syndrome, IPEX 
(Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked) in humans 
(Bennett et al. 2001, Wildin et al. 2001, Chatila et al. 2000) and analogous 
lymphoproliferative disease in Scurfy mice (Brunkow et al. 2001). Autoimmune 
manifestations include, among others, massive lymphoproliferation, diabetes, eczema 
and severe diarrhea (Torgerson and Ochs 2007). In addition, experiments in mice 
have revealed that the mutation of FoxP3 leads to a massive proliferation of T cells 
specific to both self and non-self, and a concomitant activation and expansion of 
myeloid cells, including DCs and granylocytes (Ziegler 2006). Moreover, the level of 
FOXP3 expression is important. Reduced FoxP3 expression leads to an autoimmune 
disease in mice (Wan and Flavell 2007). Similarly in humans, the FOXP3 level 
correlates with suppressive function (Allan et al. 2008, Wang et al. 2007). 
 
4.2.2 Control of FOXP3 expression 
TCR mediated signals are considered to be central in the FOXP3 up-regulation during 
development (Fontenot et al. 2005). The TCR stimulation has been observed to affect 
directly the FOXP3 promoter (Mantel et al. 2006). Also several epigenetic factors are 
important in controlling the FOXP3 expression.  
 31
 CpG motifs in the FOXP3 promoter are nearly totally demethylated in the 
Treg cells. Additionally, there is a stronger association of the FOXP3 promoter with 
acetylated histones in Treg cells than in conventional T cells, suggesting that the 
FOXP3 promoter is more accessible in the Treg cells. A TGF- sensitive element, 
containing binding sites for transcription factors, has also been identified in the 
FOXP3 locus. In addition, there is another highly conserved region in the FOXP3 
locus which has also been observed to be completely demethylated in the Treg cells 
and methylated in the conventional T cells. Demethylation of this area is assumed to 
affect the stability of FOXP3 expression (Huehn et al. 2009). 
In addition to epigenetic modifications, FOXP3 has been reported to have 
interactions with chromatin remodeling enzymes, histone acetyltransferases and 
histone deacetylases, which result in the modification of the FOXP3 binding sites, 
facilitating FOXP3 function. Acetylation of the forkhead domain of FOXP3 is also 
associated with optimal Treg function. Small non-coding RNAs, microRNAs 
(miRNAs) involved in the regulation of gene expression have recently turned out to 
have a role also in the Treg cell biology. The miRNAs,( especially miR155), are 
involved in the Treg cell development in the thymus and seem also to be essential for 
homeostasis and the function of Treg cells (Sakaguchi et al. 2008, Huehn et al. 2009).  
 
4.2.3 Functions of transcription factor FOXP3 
FOXP3 is a member of the forkhead/winged-helix family of transcriptional 
regulators. There are 11 exons in the FOXP3 gene. It acts both as a transcriptional 
activator and repressor with numerous target genes. It likely regulates gene expression 
both directly and indirectly. FOXP3 affects other transcription factors, for example a 
direct interaction and inhibition of NFAT is observed. FOXP3 actively regulates the 
expression of many characteristic surface markers of Treg cells. It also down-
regulates production of IL-2, IL-4 and IFN- and ablation of FoxP3 restores the 
ability to produce IL-2. FOXP3 regulates IL-2 only after TCR stimulation, whereas 
surface molecules CD25 and CTLA-4 are constantly up-regulated by FOXP3 (Zheng 
et al. 2007). FOXP3 seems to affect also TCR signaling. The early signaling events 
are reduced, including phosphorylation of CD3 and subsequent recruitment of 
ZAP70 (Tsang et al. 2006). In addition actin reorganization has also been reported to 
be affected (Tsang et al. 2006). Actin reorganization is required for sustained TCR 
signaling (Miletic et al. 2003) and thus FOXP3 action may lead to diminished TCR 
signaling in Treg cells. In vitro, Treg cells proliferate poorly (Baecher-Allan et al. 
2001, Itoh et al. 1999, Li et al. 2005).  
In humans FOXP3 is expressed as three isoforms, the full-length version, an 
isoform lacking the exon 2 (FOXP32) (Allan et al. 2005) and a third splice variant 
that lacks both exon 2 and exon 7 (FOXP3Smithet al. It was recently 
reported that the full-length form of FoxP3 inhibits RORDuetal and 
RORt (Ichiyama et al. 2008) mediated transcriptional activation. RORand RORt 
expression up-regulates some Th17 cell related genes. The FOXP32 isoform is 
unable to interact with RORand RORt, because the binding site is located in exon 
2. Thus only the full-length form of FOXP3 may suppress the induction of Th17 
differentiation.  
FOXP3fails to induce Treg cell associated surface markers CD25 and 
CTLA-4 and it does not confer suppressive capacity to transduced CD4+CD25+ cells. 
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 FOXP3Δ2Δ7 may have a role in regulating the function of the other FOXP3 isoforms 
and it may be involved in cancer pathogenesis (Mailer et al. 2009). 
 
4.3 Surface markers of Treg cells 
Albeit FOXP3 is at the moment the most specific marker for Treg cells, as an 
intracellular transcription factor its usage in Treg cell identification is restricted. 
Many cell surface markers have been identified to recognize Treg cells among 
effector T cells. As many markers are expressed equally by activated effector cells 
and Treg cells, the differentiation of these two populations is often difficult. Although 
the markers are used for the characterization of this cell population, they are not only 
markers, but have also have functional significance. 
 Most commonly used cell surface marker is CD25, which is richly expressed 
on Tregs (Sakaguchi et al. 1995). A complicating factor is that effector T cells also 
up-regulate CD25 upon activation, in spite of that Tregs are generally identified as 
CD4+CD25high cells. As CD25 is the  chain of IL-2R, its expression is pertinent for 
regulatory T cells since IL-2 is crucial for the maintenance and function of regulatory 
T cells (Furtado et al. 2002, Malek and Bayer 2004). Cytotoxic T Lymphocyte 
Antigen 4 (CTLA-4, CD152) is constitutively expressed both intra-cellularly and on 
the cell surface of Treg cells. CTLA-4 is involved in regulating immune tolerance 
(Takahashi et al. 2000, Read et al. 2000). In humans, another characteristic for Treg 
cells is the low expression of IL7-R or CD127 (Liu et al. 2006, Seddiki et al. 2007, 
Hartigan-O’Connor et al. 2007), although usability of this feature has also been 
disputed, since CD127 is down-regulated early during T cell activation. 
Glucocoricoid-induced tumor necrosis factor receptor (GITR) has also been reported 
to be expressed by the majority of Treg cells, but it is also expressed by effector T 
cells. It is a co-stimulatory molecule, which activates effector T cells and modulates 
Treg cells. It has been reported that GITR engagement can inhibit Treg cells or 
render effector T cells more resistant to Treg-mediated suppression (Shimizu et al. 
2002, Nocentini and Riccardi 2005). Several other molecules have also been 
identified on the cell surface of Treg cells, e.g. L-selectin (CD62L), CD45RO, CD69, 
LAG-3, neuropilin-1, CD103 and OX-40 (Qu and Zhao 2007). However the 
selectivity of these markers is arguable, especially in humans.  
FOXP3 regulates the transcription of many Treg-specific markers. For 
example CD25, CTLA4 and GITR are induced by FOXP3 (Chen et al. 2006) and 
CD127 is respectively negatively regulated (Liu et al. 2006).  
 
4.4 Commitment to Treg cell lineage  
The developmental pathway through which Treg cells arise is still ambiguous. The 
precise phase of development when regulatory T cells diverge from other thymocytes 
is unclear. The original view has been that TCR/MHC interactions are essential for 
the up-regulation of FOXP3 and Treg cells diverge from the CD4-lineage rather late 
during thymic development (Fontenot et al. 2005, Liston and Rudensky 2007).  
 
4.4.1 FoxP3+ thymocyte subsets 
Findings in mice have shown that the majority of FoxP3+ cells are found at the 
CD4+CD8- SP stage. Additionally, a small population of CD4+CD8+ DP thymocytes 
expressing FoxP3 has been described in several publications (Fontenot et al. 2005, 
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 Liston et al. 2008, Cabarrocas et al. 2006, Wan and Flavell 2005). Nevertheless, 
FoxP3 expression is clearly detected also in some DN and CD8+ SP thymocytes 
(Cosmi et al. 2003, Fontenot et al. 2005). Most mature CD4+CD25+FoxP3+ 
thymocytes already share phenotypic and functional characteristics of their peripheral 
counterparts (Liotta et al. 2005). Expression of other characteristic Treg markers, such 
as GITR and intracellular CTLA4, are also detected from DP CD25+ cells (Cosmi et 
al. 2003, Annunziato et al. 2002). The relationship of these DP cells to the more 
mature Treg cells however remains unclear, some stating a developmental 
relationship between DP and SP Treg cells while others contest it. In addition, human 
CD8+CD25+ thymocytes expressing FOXP3 have been reported to share many 
features with the CD4+CD25+ regulatory thymocytes. Similarly they could suppress 
the proliferation of both CD4+CD25- and CD8+CD25- T cells (Cosmi et al. 2003). In 
other studies the expression level of CD25 on CD8+FOXP3+ was lower than that of 
CD4+ thymocytes (Cupedo et al. 2005). The developmental pathway and relationship 
of CD8+CD25+ regulatory T cells with other FOXP3+ subsets is unknown. 
 
4.4.2 Evidence for commitment in SP stage 
The majority of the FoxP3+ thymocytes have been shown to localize in the medulla 
and the expression of FoxP3 is largely restricted to the CD4+ SP cells. Hence the 
major events of Treg cell development are thought to take place in the thymic 
medulla. Spesifically, it has been argued that there is no preceding FoxP3+ DP 
population in mice, but FoxP3+ DP cells emerge in parallel with FoxP3+ SP cells, thus 
no progression from the FoxP3+ DP to FoxP3+ SP population takes place (Fontenot et 
al. 2005). It is thought that the high affinity interactions with mTECs and thymic DC 
direct T cells to Treg lineage (Bensinger et al. 2001, Aschenbrenner et al. 2007). It 
has also been suggested that in addition to TCR mediated signals cytokines are 
needed to induce the up-regulation of FOXP3 and complete the commitment to the 
Treg cell lineage in the thymic medulla (Burchill et al. 2008, Lio and Hsieh 2008).  
 
4.4.3 Evidence for commitment in DP stage 
An increasing number of studies argues that also cortical epithelial cells are sufficient 
for supporting Treg cell differentiation. CCR7 -/- mice, which have impaired 
trafficking of developing thymocytes from cortex to medulla, export mature T cells to 
the periphery directly from the cortex (Kurobe et al. 2006). Thus the thymic cortex 
appears to be capable of supporting the development of mature thymocytes. It is 
proposed that the cortex is at least capable of inducing the development of Treg cells, 
since FoxP3 is up-regulated already at the double-positive cell stage. However the 
final commitment may occur in the medulla (Bensinger et al. 2001, Pacholczyk et al. 
2002).  
Alternatively, it has been recently published that a considerable proportion of 
FoxP3+ SP cells acquired FoxP3 expression as cortical DP cells (Liston et al. 2008, 
Ribot et al. 2007). Then cortical DP Foxp3+ cells migrate rapidly to the medulla 
(Liston et al. 2008). Another study also showed a clear increase of Treg cell 
precursors already at DP cell stage. Moreover developing thymocytes in these double-
transgenic mice, which express a neo-self-Ag for hemagglutinin(HA) in thymic 
stroma and transgenic TCR specific for HA in T cells, could acquire Treg markers 
CD25 and FoxP3 before negative selection, implying divergence to Treg lineage 
before the entrance to the medulla (Cabarrocas et al. 2006, Ribot et al. 2007). A recent 
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 study showed that in reaggregate cultures Treg precursors were competent to express 
FoxP3 immediately after  rearrangements (Relland et al. 2009). 
 
4.4.4 Evidence for commitment in DN stage 
There are also data suggesting that the commitment to Treg lineage may occur already 
before FoxP3 is up-regulated. Recent reports in mice demonstrated that when FoxP3 
expression was disrupted by insertion of GFP (green fluorescent protein) into the 
FoxP3 locus, the GFP+ cells shared many features with their FoxP3+ counterparts in 
the absence of FoxP3 expression. The precursors of FOXP3 + cells had their Treg 
characteristics at an early stage and up-regulation of FOXP3 stabilized the phenotype, 
thus the Treg cell lineage commitment seem to occur already before up-regulation of 
FOXP3 (Gavin et al. 2007, Lin et al. 2007). Another recent report proposed that DN 
precursors, which have not yet rearranged TCR genes, are affected by DP cells, some 
precursors becoming more susceptible to differentiate to Treg cells after additional 
signals (Pennington et al. 2006).  
 
4.5 Selection and TCR specificities of Treg cells 
The TCR repertoire of Treg cells seems to be polyclonal and more diverse than the 
repertoire of other CD4+ T cells (Pacholczyk et al. 2006). Current understanding has 
strongly favored the idea that Treg cells bear self-reactive TCRs. The main theory is 
that the commitment to Treg cell-lineage is defined by an increased affinity of the 
TCR (Kawahata et al. 2002, Apostolou et al. 2002, Walker et al. 2003, D’Cruz and 
Klein 2005). Thus thymocytes recognizing self-peptide:self-MHC complexes with 
intermediate to high affinity or affinity nearly at the level that would normally induce 
negative selection/deletion would direct cells to Treg-lineage. The model is based on 
observations of numerous mouse models in which the numbers of Treg cells increase 
when TCR transgenic thymocytes encounter their transgene-encoded ligand in thymic 
stroma (Jordan et al. 2001, Hsieh et al. 2004, Romagnoli et al. 2002).  
Supporting data for the hypothesis that TCRs used by Treg cells are self-
reactive were acquired from experiments where TCRs of activated CD4+CD25+ T 
cells from FoxP3-deficient TCR-transgenic mice were compared with TCRs of 
regulatory or non-regulatory T cells from FoxP3+ TCR-transgenic mice. There was 
an obvious over-representation of TCRs usually found in Treg cells in the repertoire 
of activated CD4+ CD25+ FoxP3-deficient population. Thus conventional T cells 
share autoreactive TCR-specificities with Treg cells, but FoxP3+ Treg cells normally 
keep these self-reactive T cells in check (Hsieh et al. 2006). Again, to study the 
specificity of TCR expressed by Treg cells, transgenic mice expressing Treg-TCR 
were generated. Over 90 % of CD4+ T cells were deleted indicating that the TCR was 
specific to some naturally expressed self-peptide in the thymus. The deletion occurred 
rather late during the development suggesting that the ligand for TCR existed and the 
selection took place in the medulla (DiPaolo and Shevach 2009). However, the 
expression of Treg-TCR did not increase the development of FoxP3+ CD4 T+ cells.  
Since the thymic medulla is reported as the most important site for Treg cell 
differentiation and Treg cells are profiled as self-specific, mTECs promiscuously 
expressing peripheral tissue antigens doubtless play an important role. In addition 
DCs can present antigens captured from mTECs. Recent study showed evidence that 
PTAs, expressed under control of AIRE, affect to the TCR repertoire of Treg cells 
(Aschenbrenner et al. 2007). 
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 Despite the several published observations stating that Treg cells have TCRs 
specific for self-peptide:self-MHC complexes, contradictory results have been 
presented. Instead of enhanced formation of Treg cells, there are challenging reports 
suggesting selective survival for Treg cells when encountering their cognate ligand. It 
has been reported that increase of regulatory T cells, while interacting with variable 
amounts of their cognate antigen, does not occur or is minimal. Instead CD4+CD25+ 
cells seem to be more resistant to deletion and this way appear to be enriched in the 
presence of their ligand (van Santen et al. 2004). Another recent report demonstrated 
that the Treg TCR repertoire is shaped by affinity-based selections, similar to that of 
conventional T cells, and FoxP3 induction is an independent process. Both FoxP3+ 
and FoxP3- cells were negatively selected when confronting high affinity ligands, the 
extent of deletion being significantly lower among the FoxP3+ thymocytes, which 
again suggests that developing Treg precursors are more resistant to negative 
selection (Relland et al. 2009). The ligands, that mediate negative selection and 
FOXP3 induction of Treg cells may be different as well as the APCs that mediate 
each process. 
There are several reports arguing that Treg cells also recognize foreign 
antigens. A recent study discovered that autoreactive TCRs specific for abundant self-
MHC-peptide complexes were rare on all CD4+ T cells, yet more common among 
Treg cells than conventional T cells (Pacholczyk et al. 2007). In other studies where 
the TCR repertoires of FoxP3+ regulatory T cells were compared with other CD4+ T 
cells, the repertoires proved to be more or less overlapping, with similarities ranging 
from 10 % to 42 % (Pacholczyk et al. 2006, Hsieh et al. 2006, Wong et al. 2007, 
Fazilleau et al. 2007). The widely diverse repertoire helps to explain how Treg cells, 
in addition to self antigens, recognize foreign antigens as well. 
 
4.6 Cytokines and additional signals 
Albeit TCR signaling is considered to be essential, development of Treg cells is 
influenced by cytokines. IL-2, though not produced by Treg cells themselves, is 
indispensable for their development and peripheral maintenance. Numerous 
experiments performed using mouse models where some component of IL-2 
signaling, IL-2, CD25, IL-2R, or STAT5 is disrupted have shown that IL-2 is 
specifically required for the development and maintenance of Treg cells (Ziegler 
2006). Recent studies have proposed that signaling through IL-2 receptor would elicit 
STAT5, which in turn is capable of inducing FOXP3 (Yao et al. 2007, Burchill et al. 
2007). However, results showing that IL-2 is not crucial for FOXP3 expression and 
the establishment of Treg cells during thymic development, have also been reported 
(D’Cruz and Klein 2005, Fontenot et al. 2005). Instead, other common  chain (c) 
dependent cytokines can compensate for the absence of IL-2. Common c-deficient 
mice have complete deficiency of FoxP3+ Treg cells (Fontenot et al. 2005). For 
example IL-15 is capable of inducing FoxP3 expression, but its potency is much 
weaker than IL-2 (Imamichi et al. 2008).  
IL-7 promotes proliferation and survival of all thymocytes as well as mature 
peripheral T cells. Additionally, thymic stromal lymphopoietin (TSLP) can also signal 
through IL-7 receptor (IL-7R). IL-7R (CD127) is richly expressed on thymocytes and 
naïve T cells generally. However, Treg cells seem to develop and function normally 
in IL-7-deficient mice and Treg cells express low levels of IL-7R (Bayer et al. 2008). 
It has also been speculated that IL-7R signaling affects thymic Treg cell progenitors 
early during differentiation, at a stage distinct from which IL-2 functions 
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 (Mazzucchelli et al. 2008). In total, analyses of mice indicate that neither IL-7 nor IL-
15 are required when IL-2R signaling is possible (Bayer et al. 2008).  
The co-stmulatory CD28 molecule has shown to be essential for thymic Treg 
development (Sansom and Walker 2006). The role of TGF- in the thymic 
developmet of Treg cells is still under debate, but TGF-and CD28 seem to have 
importance in the maintenance and homeostasis of natural Treg cells in the periphery 
(Tang et al. 2003, Marie et al. 2006, Marie et al. 2005, Li et al. 2006). Also the 
CD40/CD40L interaction is reported to contribute to homeostasis of Tregs in the 
periphery (Guiducci et al. 2005). 
Recently a two-step model of Treg cell differentiation has been generated. 
According to this model, signaling through TCR and co-receptor CD28 is initially 
required, but additional signaling through cytokines completes the differentiation that 
triggers the expression of FOXP3 (Burchill et al. 2008). In accordance with this 
model, recent data suggest that cells among CD4+ SP thymocytes, which are recently 
activated through TCR, become CD25high. These cells also express GITR and CD69 
and are immediate precursors of Treg cells. In addition, the TCR repertoire of Treg 
cells was more similar to CD25high GITRhigh cells than CD25low GITRint proposing that 
CD25high cells were alredy selected by TCRs characteristic for Tregs (Lio and Hsieh 
2008). 
Probably several cell types can influence Treg cell development in the thymus, 
since cTECs, mTECs and DCs all have exhibited possible effects on Treg cell 
development. Hassall’s corpuscles have been shown to support the development of 
Treg cells. TSLP is expressed by Hassall’s corpuscles and activates CD11c-positive 
immature DCs to up-regulate MHC class II molecules and B7 co-stimulatory 
molecules. These primed DCs were thereafter capable of inducing proliferation and 
differentiation of CD4+CD8-CD25- thymic T cells into CD4+CD25+FOXP3+ Treg 
cells in humans (Watanabe et al. 2005). In mice, TSLP also supports Treg cell 
development, but unlike in humans, the cytokine seems to act directly on FoxP3- 
CD4+ SP thymocytes (Jiang et al. 2006). 
 
 
5 PERIPHERAL TOLERANCE 
 
In spite of the negative selection during the T cell development some autoreactive 
cells always escape to the periphery. There are several mechanisms to keep these cells 
in check, the Treg cells probably being among the essential mediators of peripheral 
tolerance. 
 
5.1 Natural Treg cell function 
It has been well established that Treg cells are able to suppress the proliferation of 
other T cells. Fundamental to the Treg cell function is that the suppression is TCR-
dependent, that is, the CD4+CD25+ Treg cells must be stimulated via TCR to exert 
suppression. Additionally, the Treg cells are highly sensitive to antigenic stimulation, 
and much lower antigen quantities are sufficient for activation when compared to 
conventional T cells. However, once the Treg cells are stimulated by a specific 
antigen, they can suppress both the CD4+ and CD8+ T cells, and the suppression they 
mediate is antigen-nonspecific (Sakaguchi 2004).  
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 The hallmark for Treg cell function has been the dependence of cell-to-cell 
contacts. Nonetheless, it has been questioned whether actual contact is required or 
whether close proximity of the cells is sufficient. Natural Treg cells are shown to 
suppress naïve and effector T cells, as well as affect the function of NK cells, NK-T 
cells, B cells, DCs and macrophages. They have various mechanisms of suppression. 
It has also been suggested that there are subpopulations of the FoxP3+ Treg cells with 
different functional properties (Sakaguchi et al. 2008, Vignali et al. 2008, Gupta et al. 
2008).  
 
5.1.1 Cellular contacts 
Several studies clearly indicate that the regulation of effector T cells occurs in part 
through the regulation of APCs. Because APCs are required for the activation of 
effector T cells, these cells are at a fundamental point of control. It has been suggested 
that Treg cells affect both the maturation and function of DCs. It was recently 
published that, in mice, CTLA-4 on the cell surface of Treg cells mediates down-
regulation of B7 molecules on APCs, thus limiting the potency of APCs to activate T 
cells (Wing et al. 2008). Treg cells can also induce up-regulation of the IDO enzyme 
(indoleamine 2,3-dioxygenase) in DCs. IDO catalyzes breaking down of tryptophan 
and deprivation of tryptophan inhibits the entry of the cell to cell cycle. Additionally, 
tryptophan metabolites, kynurenines, are toxic and induce apoptosis. Consequently 
proliferation of T cells is inhibited. Also up-regulation of IDO appears to be CTLA-4 
dependent. LAG3 (lymphocyte activation gene 3), which is up-regulated upon Treg 
activation, is suggested to suppress the maturation of DCs and it has also been 
proposed to engage and inhibit effector T cells. Direct suppression of effector T cells 
through CTLA-4 may also happen (Vignali et al. 2008, Gupta et al. 2008, Tang and 
Bluestone 2008, Maggi et al. 2005). 
 
5.1.2 Cytokines 
Suppression of effector T cells through inhibitory cytokines is one of the well 
established means. IL-10 and TGF- are thought to function as suppressor molecules 
of Treg cells. However, contribution of these cytokines on the function of thymus-
derived Treg cells is unclear, since these cytokines are used by peripherally induced 
Treg cells as well. Treg cells also modulate cytokine production by DCs. TGF- may 
function also in a cell contact-dependent manner, since Treg cells may have it bound 
on their cell surface as well (Vignali et al. 2008, Tang and Bluestone 2008). In mice, a 
third important cytokine mediating suppression is the recently described cytokine IL-
35, which has been stated to be required for maximal suppression (Collison et al. 
2007). However, human Treg cells were not found to express detectable amounts of 
IL-35 (Bardel et al. 2008).  
Another way for regulating effector T cells is thought to occur through 
changes in the metabolism of effector cells. It has been suggested that inhibition of 
the production of cytokines, especially IL-2, by Tregs results in apoptosis of effector 
cells. In addition, pericellular adenosine or intracellular cAMP introduced to the 
effector cells is described to inhibit their function. Treg cells are able to suppress 
target cells also by killing through cytolysis. Human Treg cells have been noted to 
secrete granzyme A and perforin, in mice granzyme B has been detected (Vignali et 
al. 2008).  
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5.1.3 Suppressive role of Treg cells in immune responses 
Regulatory T cells are reported to have diverse effects on immune responses and are 
important to the maintenance of tolerance to many tissue-specific antigens. Mutations 
in FOXP3 gene cause the complete absence of Treg cells, leading to multiorgan 
inflammation and destruction or IPEX. This disease is described in more detail in 4.2. 
Several more common autoimmune conditions have also been linked to defects in 
Treg cells. These include colitis, inflammatory bowel disease, multiple sclerosis and 
rheumatoid arthritis. Treg cells can also play a role in modulating immune responses 
against microbes. They limit inflammation and prevent the development of excessive 
immune responses. On the other hand, they may promote persistence of the pathogen 
and thereby allow a chronic infection. They may also dampen antitumor immunity 
and prevent the eradication of malignant cells (Piccirillo 2008, Sakaguchi et al. 2008, 
Vignali et al. 2008). Recently it was also reported that the number of Treg cells is 
reduced in abdominal fat of obese mice and Treg cells influence the inflammatory 
state of adipose tissue and insulin resistance (Feurer et al. 2009, Winer et al 2009). 
 
5.1.4 Activating role of Treg cells in immune responses 
In contrast to their suppressive role, it was lately published that instead of suppression 
Treg cells contributed to early immune responses against local virus infection. It was 
shown that the ablation of Treg cells impaired the migration of antiviral effector cells 
to the infection site. In addition in the absence of Tregs there was an increased 
pathogen replication and altered chemokine milieu in secondary lymphoid organs 
(Lund et al. 2008). Thus in some situations Treg cells seem also able to promote 
defence against pathogens. 
 
5.2 Peripheral conversion of Treg cells 
Natural Treg cells develop in thymus, yet cells with regulatory properties are also 
converted from conventional T cells in the periphery. Peripheral development of Treg 
cells likely generates also cells specific to foreign antigens. However, there is some 
disagreement whether activation-induced Treg cells can act as suppressors and are 
functionally stable.  
 
5.2.1 Peripheral induction of FOXP3+ Treg cells 
The cytokine milieu in which T cells are activated plays an important role in 
determining the phenotype of induced suppressor or effector cells. TGF- is reported 
to participate in the peripheral generation of Treg cells. Retinoic acid, produced by 
DCs, enhances the differentiation to FoxP3+ Tregs as retinoic acid inhibits IL-6 driven 
programming to Th17 cells. Especially CD103+ DCs in the mesenteric lymph nodes 
and the small intestine lamina propria promote induction of FoxP3+ Treg cells 
through TGF- and retinoic acid-dependent mechanism. These induced Treg cells are 
thought to contribute to mucosal tolerance and homeostasis (Benson et al. 2007, 
Coombes et al. 2007, Sun et al. 2007, Mucida et al. 2007). Also IL-2 is reported to be 
important for peripheral Treg generation, since it inhibits induction towards Th17 
cells (Laurence et al. 2007). The relationship of peripheral induction between Th17 
cells and Treg cells seems to be intimate. Additionally it has been shown in both mice 
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 and humans that IL-17 producing cells can develop from FoxP3+ Treg cells (Voo et 
al. 2009, Xu et al. 2007). Further, cells co-expressing both FoxP3 and RORt have 
been reported (Zhou et al. 2008). 
Recent studies analyzing TCR repertoires have shown a clear overlap between 
the TCR repertoires of thymic and peripheral FoxP3+cells, or respectively between 
thymic and peripheral conventional TCR repertoires. This indicates that a 
considerable proportion of peripheral Treg cells in mice are of thymic origin and are 
not recruited from conventional T cells in the periphery upon contact with self-
antigens (Hsieh et al. 2006). Another report also stated that peripheral conversion had 
no prominent contribution to the normal Treg cell population, with the conversion 
being, however greater in a lymphopenic environment (Relland et al. 2009). Several 
TCRs from converted Treg cells in lymphopenic hosts could also be found in the 
normal thymic Treg cell popoulation. These data suggest that peripheral conversion is 
not an automatic consequence of T cell activation, but it is the TCR specificity that 
determines the capability of the cell to undergo conversion (Lathrop et al. 2008). The 
extent of the peripheral conversion thus remains controversial, being probably more 
common in humans.  
In humans it has been reported that a fraction of the regulatory population is 
generated from rapidly dividing, highly differentiated memory CD4+ T cells. A 
comparison of the TCR repertoires of the regulatory CD4+CD25high and memory 
CD4+CD25- T cells suggested that these populations are derived from the same clonal 
precursors (Vukmanovic-Stejic et al. 2006). 
 
5.2.2 Nonregulatory induction of FOXP3  
Activation induced up-regulation of FOXP3 is not necesserily associated with 
suppression and is widely seen in humans. However, the level of FOXP3 is then 
transient and substantially lower when compared to natural Treg cells (Allan et al. 
2008, Walker et al. 2005, Yagi et al. 2004, Walker et al. 2003, Allan et al. 2007). 
Surface molecules expressed by these activated FOXP3+ cells are similar to natural 
Treg cells. The production of cytokines, for example IL-2 and IFN- by recently 
activated FOXP3+ cells continues and it is reported to diminish over time. It is 
suggested that a prolonged expression of FOXP3 is required for suppression of 
cytokine secretion and, at least in humans, regulatory properties also require 
prolonged expression of FOXP3 (Allan et al. 2007, Gavin et al. 2006, Roncador et al. 
2005). However, in vitro studies of human T cells showed that stimulation of 
CD4+CD25- cells with IL-15 or IL-2 and without TCR stimulation, led to sustained 
high levels of FOXP3 and CD25, but not to suppressive capacity (Imamichi et al. 
2008).  
 
5.3 Other mechanisms of peripheral tolerance 
In addition to active suppression, there are also other mechanisms to maintain 
tolerance. Activation of T cells is restricted to secondary lymphoid tissues, mainly to 
lymph nodes, where antigens are presented, typically by DCs. In addition DCs have to 
be activated by a pathogen, since immature DCs are not very effective in stimulating 
naïve T cells (Mellman and Steinman 2001). Naïve T cells circulate predominantly 
between blood and lymph nodes and no entry to tissues occur without activation. 
Thus naïve T cells do not recognize their antigens if antigens are not properly 
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 presented with costimulatory molecules. Physical boundaries, for example the blood-
brain barrier, are another mechanism to avoid T cell activation (Simpson 2006). 
In addition to the negative selection during thymic development, T cells are 
deleted also in the periphery. Sometimes during the antigen presentation by APCs, 
mainly dendritic cells, T cells are directed to die through programmed cell death 
instead of activation. At first, a naïve T cell however gets activated and also 
proliferates, but during the clonal expansion it is directed to apoptosis. The 
mechanisms that lead DCs to give different signals are unclear. DCs can take up and 
process antigens originating from nearby tissues and present them in MHC class I 
molecules. This is referred to as cross-presentation and it is thought that cross-
presentation supports signals leading to deletion. Particularly deletion of CD8+ T cells 
is considered as an important tolerance mechanism (Heath and Carbone 2001).  
Yet another way to prevent unsuitable immune responses is anergy. Anergic T 
cells are unresponsive to their specific antigen. It is a consequence of unsuccessful 
activation. Anergy arises when a T cell does not receive appropriate co-stimulation 
during antigen recognition or the antigen recognized triggers inadequate signaling 
through TCR. Anergic T cells are incapable of producing IL-2 (Mellman and 
Steinman 2001, Schwartz 2003, Zouali 2007, Van Parijs and Abbas 1998).  
 
 
6 FAILURE OF TOLERANCE: APECED AS A MODEL 
 
Autoimmunity ensues, when tolerance to self breaks. Autoimmune diseases affect 3-5 
% of the population. These diseases are divided into systemic and organ-specific or 
localized autoimmune disorders. Some are caused by autoantibodies, for example 
myasthenia gravis, and some by T cells, for example type 1 diabetes, although also 
antibody-mediated pathways cause tissue injury in diabetes (Greeley 2002). The 
background of autoimmunity is complicated, both genetic and environmental factors 
have role in the disease’s induction (Marrack et al. 2001, Santamaria 2001).  
Some rare monogenic diseases have been recognized. Since APECED 
(Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy) results from a 
mutation of a single gene, it is an interesting and valuable disease model (Perheentupa 
2006), especially since AIRE (AutoImmune Regulator) is linked to thymic 
development, and natural Treg cell development occurs in the thymus. 
 
6.1 Human disease 
APECED or Autoimmune Polyendocrine Syndrome type I (APS-1) is a recessively 
heritable monogenic autoimmune disease, caused by mutation in the AIRE gene 
(Finnish-German APECED Consortium 1997, Nagamine et al. 1997). It belongs to 
the Finnish disease heritage. This rare disease is enriched also in Iranian Jews and 
Sardinians. Approximately 90 % of the Finnish patients carry the Finnmajor mutation, 
R257X (Perheentupa 2006), which is also the most common mutation worldwide.  
The clinical picture varies, but the most common manifestations, the classic 
triad, are mucocutaneous candidiasis, hypoparathyroidism and adrenocortical failure 
(Addison’s disease). Candidiasis occurs at least occasionally in all patients and it is 
often the first symptom of APECED. Other components of the disease are e.g. 
gonadal failure, type 1 diabetes, pernicious anemia, malabsoprtion, enamel 
hypoplasia, alopecia, nail dystrophy and keratoconjunctivitis. The onset of the disease 
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 occurs usually in childhood and new components may evolve throughout life. Adult 
patients have on average five disease components, but some individuals suffer from 
up to ten components (Perheentupa 2006, Ahonen et al. 1990, Perheentupa 2002). 
Clear correlations between the type of mutation and the phenotype have not been 
shown. The manifestations vary substantially, as much between siblings than between 
other patients, hence one can assume that there are other genetic and environmental 
factors besides the AIRE mutation that affect the phenotype (Ahonen et al. 1990). 
Yet, it has been noted that patients lacking the Finnmajor mutation have a decreased 
prevalence of chronic mucocutaneous candidiasis (Halonen et al. 2002).  
In the absence of a functional AIRE gene product, autoreactive T cells may 
escape to the periphery because of the disturbed negative selection, due to the lack of 
expression of PTAs in thymus (Anderson et al. 2002, Liston et al. 2003). Various 
autoantibodies against components of the target tissues are also present. The 
autoimmune tissue destruction appears similar to that observed in the same tissues in 
non-APECED autoimmunity including tissue infiltrations of lymphocytes in the 
affected organs. The appearance of specific autoantibodies often precedes the clinical 
disease of the target tissue. Antibodies specific for type 1 interferons are prevalent 
and since they are specific to APECED patients, they can be used as diagnostic 
markers for the disease (Meager et al. 2006, Meloni et al. 2008).  
 
6.2 Aire knock-out mouse and ectopic transcription 
Several mouse models of APECED have been generated. The suggestion that the 
transcription factor Aire, at least in part, induces ectopic transcription of PTAs in 
mTECs, has originated from studies in Aire-/- mice (Anderson et al. 2002, Liston et al. 
2003). The absence of AIRE leads to lack of broad repertoire of PTAs, and thus the 
negative selection of thymocytes in the thymic medulla is impaired. In consequence 
autoreactive T cells escape to the periphery and autoimmune manifestations ensue. 
 However, the Aire-/- mouse does not mimic APECED too successfully. This 
suggests that the failure of negative selection is not enough to explain the disease 
manifestations seen in APECED. Different kinds of mutations have been targeted and 
different mouse backgrounds have been used. The background of mice has been 
shown to have influence on the phenotype, with the autoimmune-prone nonobese 
diabetic (NOD) mouse getting the most severe autoimmune characteristics (Niki et al. 
2006, Jiang et al. 2005). In most backgrounds the phenotype of the mice is mild and 
they are clinically fairly healthy. 
There are, nonetheless, signs of immunological dysregulation. T cells are 
hyperreactive and there are disturbances of the TCR repertoire. In addition, tissue 
infiltrates and autoantibodies have been detected (Anderson et al. 2002, Ramsey et al. 
2002, Kuroda et al. 2005). However, the symptoms and target tissues differ from the 
manifestations of APECED, with the exception of perturbations of fertility. 
Additionally, Aire-deficient mice do not seem to be susceptible to candidiasis (Hubert 
et al. 2009).  
Treg cells are reported to develop and function normally in Aire-/- mice 
(Liston et al. 2003, Kuroda et al. 2005, Anderson et al. 2005). Mice lacking both Aire 
and Foxp3 show pronounced autoimmune manifestations compared to mice with only 
one mutation (Chen et al. 2005). These results suggest that in mice functional Treg 
cells may curtail potentially pathological immune reactions caused by Aire-deficiency 
and keep the phenotype of Aire -/- mice mild. 
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 6.3 Other functions of AIRE 
AIRE is localized mainly in the cell nucleus (Björses et al. 1999, Heino et al. 1999, 
Rinderle et al. 1999). The AIRE protein contains several functional domains, 
including a DNA binding domain (Kumar et al. 2001, Purohit et al. 2005), and its 
structure suggests a role as a transcriptional regulator. E3 ubiquitin ligase activity has 
been suggested, but these findings have been challenged (Uchida et al. 2004, 
Bottomley et al. 2005). Since major patient mutations occur in the plant-
homeodomain (PHD) zinc fingers, these regions are probably important for AIRE 
(Björses et al. 2000).  
Several observations suggest that AIRE has other functions in addition to 
ectopic transcription. Aire-deficient mice have shown autoimmunity against antigens, 
which are retained in the thymus in the absence of Aire (Kuroda et al. 2005, Niki et 
al. 2006). It has been shown that Aire-deficient mTECs present antigens less 
efficiently. This suggests that Aire contributes also to the expression of some genes 
related to antigen processing and presentation (Anderson et al. 2005, Johnnidis et al. 
2005). Additionally, rapid apoptosis of Aire+ mTECs is detected. This may be a 
mechanism to promote the cross-presentation of the peripheral-tissue antigens they 
produce (Gray et al. 2007).  
In addition mTECs, it has been reported that AIRE is expressed at low levels 
on B cells and some thymocytes, mainly DP cells (Suzuki et al. 2008). In one report 
Aire-deficiency is reported to cause developmental block in the late stage 
differentiation of CD4 SP cells in mice, although the mechanism remained 
undetermined (Li et al. 2007). However, later studies have shown that Aire affects 
thymic organization and maturation of mTECs (Yano et al. 2008), and thus the altered 
thymic microenvironment in Aire-deficiency may affect the maturation of 
thymocytes.  
Aire is detected also to a lesser extent in DCs (Anderson et al. 2002, Anderson 
et al. 2005, Hubert et al. 2008). Aire is described to affect the differentiation and 
function of DCs. Aire-/- DCs induced stronger stimulation of T cells, which was in 
part influenced by the increased expression of VCAM-1 on APCs (Ramsey et al. 
2006). In APECED patients, DCs are shown to be functionally impaired, responding 
poorly to microbial stimuli (Pontynen et al. 2008).  
It was recently published that Aire is also expressed in secondary lymphoid 
tissues of mice, in cells referred to as extrathymic Aire-expressing cells (eTACs). 
These cells were capable of interaction with naïve T cells, followed by deletion of 
self-specific T cells. They had characteristics of professional APCs, but were non-DC 
and resembled in part mTECs. eTACs were MHC class II+, but lacked the expression 
of B7 co-stimulatory molecules. AIRE-regulated expression of PTAs was detected, 
but the set of antigens differed from the antigens presented in the thymus, suggesting 
a supplementary role in maintaining immune tolerance (Gardner et al. 2008). The 
effects of AIRE thus seem to extend also beyond the thymus.  
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 AIMS OF THE STUDY 
 
 
Regulatory T cells are important in the maintenance of tolerance. Disturbances in the 
development or function of the Treg cells are linked to autoimmune manifestations of 
varying severity. Aims of this study were: 
 
 
I To characterize the earliest precursors expressing FOXP3 in the human 
thymus 
 
II  To compare and define the developmental relationship of different thymocyte 
populations expressing FOXP3 in the human thymus 
 
III To examine regulatory T cells with APECED as a model autoimmune disease  
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 SUMMARY OF MATERIALS AND METHODS 
 
 
The materials and methods of this study are described in more detail in the original 
publications I-IV. 
 
 
1 Samples 
1.1 Healthy donors (I-IV) 
Blood samples were collected from healthy adult volunteers and APECED patients. 
Additionally, when large amounts of peripheral blood mononuclear cells (PBMCs) 
were needed, buffy coats obtained from blood donors were used (Finnish Red Cross 
Blood Service, Helsinki, Finland). PBMCs were isolated by Ficoll-Hypaque density 
gradient centrifugation (Amersham Biosciences, Uppsala, Sweden). If not used 
immediately, PBMCs were cryopreserved in 10 % DMSO and 90 % FCS. 
Thymic tissue was obtained from children undergoing cardiac surgery. Thymocytes 
were released from the tissue samples by mechanical homogenization and used fresh.  
 
1.2 APECED patients (IV) 
We studied 26 APECED patients (12 males, 14 females). The mean age of the 
patients was 39.8 years (range 26–60). The AIRE mutation was verified by 
sequencing, as described (Halonen et al. 2002). Twenty-one of the patients carried the 
homozygote Finn-major mutation (R257X) in the AIRE gene. The HLA typing of the 
patients has been previously published (Halonen et al. 2002b) and the HLA-matched 
control was identified among donors studied in Mustonen et al. 1996.  
 
Table I The most common disease components in the patients studied 
 
  
  
mucocutaneous candidiasis 26/26 
Addison’s disease 22/26 
hypoparathyroidism 19/26 
hypogonadism 13/26 
hypothyroidism 9/26 
diabetes 6/26 
 
1.3 Mice (IV) 
Aire deficient C57BL/6 mice were constructed using a targeted disruption of the 
murine Aire gene, as described in Ramsey et al. 2002. The controls were parental, 
syngeneic wild-type (WT) mice. The mice were kept at specific pathogen free 
conditions at the National Public Health Institute, Helsinki, Finland. They were 
sacrificed at the age of 5-6 months. Perfused organs were frozen in liquid nitrogen 
and homogenized in a Tripure reagent (Roche, Basel, Switzerland) using an Ultra-
Thurrax apparatus (Janke & Kunkel, Staufen, Germany). 
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 2 Cell separation and flow cytometry (I-IV) 
 
2.1 Immunomagnetic sorting  
Selected subsets were isolated using monoclonal antibodies (mAbs) and magnetic 
beads (Dynal, Oslo, Norway), as instructed by the manufacturer. The bound cells 
were directly lysed. Alternatively, when necessary, the cells were detached either by 
overnight incubation in +37C or by using DETACHaBEADS (Dynal). The 
efficiency of the cell isolations was confirmed by flow cytometry. 
 
2.2 Flow cytometry  
Anti-CD3, CD4, CD5, CD8, CD25, CD39, CD45RA, CD45RO, CD69, CD127, 
CTLA-4, EpCAM, GITR, HLA-DR,  TCR and  TCR mAbs were direct 
conjugates and purchased from Becton Dickinson (San Jose, CA). FITC- or PE-
labeled anti-mouse Ig second step reagents and isotype-matched control mAbs were 
also from Becton Dickinson. mAbs against human TCR V2 and V12 were from 
Pierce (Rockford, IL), and V24 from Beckman Coulter (Fullerton, CA). 
The anti-preT mAb was a gift from Dr. M. Toribio (Universidad Autonoma de 
Madrid, Madrid, Spain). Anti-AIRE mAb was from P. Peterson (University of Tartu, 
Tartu, Estonia). Anti-human FOXP3 mAb conjugated to PE (clone 236A/E7) was 
purchased from eBioScience (San Diego, CA) and anti-FOXP3 clone 150D/E4 
(unlabeled) a gift from Dr. A. Banham (University of Oxford, Oxford, UK). A mix 
containing anti-human CD14, CD19, and CD56 mAb was purchased from Dynal.  
Cell permeabilization for intracellular protein detection was carried out by 
using a Fix&Perm kit (Caltag, Burlingame, CA) or by using a FOXP3 
Permeabilization and Fixation kit from eBioscience, both according to the 
manufacturers’ instructions.  
The flow cytometric analysis was done with a FACScan or a FACSAria 
(Becton Dickinson). For cell sorting, a FACSAria or a FACStar (Becton Dickinson) 
was used. 
 
2.3 Control staining 
Some of the subsets studied were present at extremely low numbers. Thus several 
control stainings were carried out to exclude significant levels of nonspecific staining. 
The binding of the secondary reagents in the absence of primary mAb was tested. 
Fluorescently labeled nonspecific mouse antibodies were also tested. 
 
 
3 Cell culture (III, IV) 
 
The cells were cultured in an RPMI medium (Life Technologies, Paisley, UK), 
supplemented with 10 % fetal calf serum (FCS) or 10 % heat-inactivated human AB 
serum (Finnish Red Cross Blood Service), 20 M HEPES, 2 M L-glutamine, 50 M 
2-mercaptoethanol, 100 g/ml streptomycin, and 100 U/ml penicillin. For stimulation, 
platebound anti-CD3 mAb, heat-killed Candida albicans at 2.5 g/ml, phyto- 
hemagglutinin (PHA) (Sigma Aldrich) at 5 g/ml or human insulin (Orion Pharma, 
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 Espoo, Finland) at 10, 2, or 0.4 g/ml was used. The cells were cultured in duplicate 
in 96-well plates for 5 days at +37°C in 5 % CO2. For the last 6h the cells were 
incubated with 1 Ci of 3H-thymidine/well. The cells were then harvested with a 
Skatron harvester (Newington, New Hampshire), and thymidine incorporation was 
analyzed with a liquid scintillation counter (Wallac, Turku, Finland).  
IFN- levels were determined using an ELISA with anti-human IFN- mAb 
(Endogen, Woburn, MA), as described (Skarsvik et al. 2005). 
 
 
4 PCR 
4.1 RNA/DNA isolation and cDNA synthesis (I-IV) 
Total RNA was isolated from the cells lysed with a Tripure reagent by using an 
RNeasy Mini or Midi Kit (Qiagen, Crawley, UK). First-strand cDNA was synthesized 
by using an oligo-dT-primer (Sigma, St. Louis, MO) and an AMV-reverse 
transcriptase (Finnzymes, Espoo, Finland). DNA was isolated using a QIAamp Blood 
kit (Qiagen). 
 
4.2 Quantitative PCR (I-IV)  
Quantitative PCR was carried out using primer-probe-assays and a TaqMan Universal 
PCR master mix (Applied Biosystems, Foster City, CA), the reactions were analyzed 
using an iCycler-IQ instrument (Biorad, Hercules, CA) or an ABI 7900HT (Applied 
Biosystems). With human samples, commercially available intron-spanning primer-
probe assays (Applied Biosystems) were used. The TCR C and RAG-2 assays were 
assay-by-design products. The sequences are found in the original articles. The assay 
for the murine TCR C was not designed to span an intron and therefore the mouse 
RNA was treated with DNase I (Sigma). The absence of genomic DNA was verified 
by real-time PCR. 
Reactions were run in duplicate and results were normalized against -actin, or 
GAPDH when indicated. A relative quantitation was done by comparing the results to 
a standard dilution curve.  
The amount of TCR excision circles (TRECs) was estimated by a quantitative PCR-
ELISA assay as described (Al-Harthi et al. 2000). 
 
4.3 TCR repertoire analysis (II- IV) 
The TCR repertoire analysis was performed as described (Pannetier et al. 1995). A set 
of V or V-specific primers was used with a C or C-specific primer to amplify 
the total V or V repertoire, followed by a run-off reaction with an internal FAM-
labeled C or C primer. All primers were synthesized by Sigma and Amplitaq Gold 
enzyme was used for the PCR (Applied Biosystems). The fluorescent amplification 
products were separated and detected with an ABI377 or ABI3730 sequencer 
(Applied Biosystems). For quantitation of similarity, comparative methods described 
in original articles II and IV were used. 
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 5 Immunohistochemistry (IV) 
 
Thymic tissue was fixed in formalin or frozen in liquid nitrogen. For 
immunohistochemistry, 5 m sections of the formalin-fixed tissues were dewaxed, 
heated in a microwave oven for 10 min for antigen retrieval, and stained with the 
monoclonal anti-AIRE antibodies and with goat anti-mouse IgG antibodies 
conjugated with horseradish peroxidase. For immunofluorescence, acetone-fixed, 5 
m cryostat sections were stained with the AIRE mAb, followed by FITC-labelled 
second-step reagents.  
The densities of the AIRE+ cells in the thymic medulla at or in the near 
vicinity of Hassall’s corpuscles and at more distant medullary areas were estimated in 
sections stained by the indirect immunohistochemistry or immunofluorescence 
techniques. For analysis, an Olympus BX50 microscope equipped with a CCD-
camera (Hamamatsu Photonics, Hamamatsu, Japan) was used. 
 
 
6 Statistical analyses 
 
Results are shown as mean  SD. P-values were calculated with Student’s two-tailed 
t-test, correlations with Pearson’s correlation coefficient, with a limit of P < 0.05 for 
significance. Mann-Whitney U test was used for P-values of AIRE+ cell densities in 
the different areas of the thymus. Confidence intervals were calculated at the 95 % 
level.  
 
 
7 Ethical considerations 
 
The study has been evaluated and approved by the ethical committee of the Helsinki 
University Hospital. All samples were collected in accordance with the Helsinki 
Declaration. Informed consent was obtained from the patients, adult volunteers and 
the parents of the children.  
The study using Aire knock-out mice has been approved by the ethical 
committee of animal use at the National Public Health Institute and the University of 
Helsinki as well as the State Provincial Offices of Southern Finland.  
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RESULTS  
 
 
1 Up-regulation of FOXP3 in thymus (I) 
1.1 FOXP3 expression in DN thymocytes 
FOXP3 is currently considered the best candidate for determination of CD4+ CD25+ 
Treg cells (Fontenot and Rudensky 2005, Ziegler 2006). The present opinion on Treg 
cells of thymic origin is that upregulation of FoxP3 requires TCR-mediated signals 
(Fontenot et al. 2005, Hsieh et al. 2004, Picca et al. 2006). In mice, FoxP3 is currently 
thought to be up-regulated at the CD4+CD8+ DP stage, following the surface 
expression of  TCR (Cabarrocas et al. 2006, Wan and Flavell 2005). The flow 
cytometric analysis showed that in the human thymus 8.6  2.5 % (range 4.6 - 13.2 
%) of the CD4+ SP population and 0.4  0.2 % (range 0.1 - 0.8 %) of the DP 
population expressed FOXP3. Of all FOXP3+ cells, 69.9 ± 12.8 % belonged to the 
CD4+CD8- SP subset, and 61.2 % of these cells expressed CD25 as well. According 
to earlier studies, these cells are functionally mature and indistinguishable from 
circulating CD4+CD25high Treg cells (Maggi et al. 2005). Of the rest FOXP3+ 
thymocytes, 17.9 ± 7.7 % belonged to the DP and 11.0 ± 7.2 % to the CD8+CD4- SP 
populations. However, a small subset of FOXP3+ cells was also found in the CD4-
CD8- DN subset in every thymus studied, accounting for 1.4 ± 1.1 % of all DN cells. 
The intensity of FOXP3 in the DN cells was similar to the FOXP3+ CD4+ SP cells. 
However, only 22.3 % of the FOXP3+ DN cells were CD25+. Any nonspecific 
staining was excluded. 
To ensure that the DN thymocyte population expressed FOXP3, the amount of 
FOXP3 mRNA in the isolated DN thymocytes was measured using quantitative PCR. 
Conformant with the FACS data, there was no significant difference between 
thymocytes in general and the DN cells. As a comparison, the level of FOXP3 mRNA 
in the DN thymocytes was 30 times higher than in  T cells of peripheral blood, 
which are not reported to express FOXP3. Taken together, these data attest that a 
small population of DN thymocytes express both FOXP3 mRNA and protein. 
 
1.2 TCR expression in FOXP3+ thymocytes 
The DN thymocytes represent the earliest precursors of T cells, since they have not 
yet finished TCR gene rearrangements and therefore cannot express  TCR on their 
cell surface (Blom and Spits 2006). We analyzed TCR expression in the FOXP3+ 
thymocyte subsets using FACS. The majority of all FOXP3+ thymocytes expressed 
 TCR. In the FOXP3+ CD4+ SP population, almost all of the cells were TCRhigh, 
whereas in the FOXP3+ DN population less than one third of the cells expressed  
TCR, and the TCR expression level was significantly lower than in the CD4+ SP cells 
(mean fluorescence intensity (MFI) of TCR staining 129 ± 36 vs. 256 ± 48; P < 0.01). 
Intracellular staining showed that lack of TCR on the surface of the FOXP3+ DN cells 
was not an artifact caused by TCR internalization. Expression of pT was not 
observed. These results demonstrate that a subset of FOXP3+ DN cells lacking TCR 
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 expression exists in the normal human thymus. Immunofluorescence staining showed 
that the TCR- FOXP3+ cells were localized in cortical areas of the thymus (Fig 6D).  
Most of the FOXP3+ DN thymocytes expressed CD2, an early T/NK lineage 
marker (Tangye et al. 2000), supporting the fact that the FOXP3+ DN thymocytes 
belonged already to the T cell lineage. Further analysis showed that the FOXP3+ DN 
thymocytes were not  T cells, B cells, NK cells or monocytes, excluding the 
possibility of ectopic FOXP3 expression in some other subset belonging to the DN 
thymocytes. Neither did the epithelial cells express any FOXP3.  
 
 
 
Figure 6. DN thymocytes express FOXP3 in the absence of TCR 
 
A, Flow cytometric analysis shows that the majority of FOXP3+ DN thymocytes do not yet 
express TCR on their cell surface. B, Immunohistochemical double-staining with FOXP3 and 
CD3 showed that the FOXP3+ thymocytes are still CD3 negative. Double-stained thymus 
section with red (FOXP3) and green (CD3) filter on. C, The same thymus section only with 
the green filter on, showing lack of CD3 expression in a FOXP3+ cell. D, HE- staining 
showed that FOXP3+ CD3- thymocytes are localized to the cortical areas of the thymus. 
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 1.3 FOXP3+ DN thymocytes have characteristics of Treg cells 
The FOXP3+ DN cells were CD127low, which is a feature of human peripheral blood 
Treg cells (Liu et al. 2006, Hartigan-O’Connor et al. 2007, Seddiki et al. 2006). 
Another characteristic marker of Treg cells, the intracellular expression of CTLA-4 
(Sakaguchi 2004) could be detected in most FOXP3+ thymocytes, as well as in DN 
FOXP3+ cells. There were no significant differences in the expression of either 
CD127 or CTLA-4 when comparing the FOXP3+ DN and FOXP3+ CD4+ SP cells. 
However, the expression pattern was clearly different between the FOXP3- CD4+ SP 
thymocytes and DN thymocytes. The Treg cell-associated molecules GITR and CD39 
were expressed by a subset of FOXP3+ CD4+ SP cells, but no expression was found in 
the FOXP3+ DN thymocytes.  
Of relevance was the finding that the expression of CD69, a marker associated 
with TCR-mediated signaling and positive selection in developing thymocytes (Hare 
et al. 1999, Hare et al. 2002), differed in the two FOXP3+ subsets. Of the FOXP3+ 
CD4+ SP cells 80.8 % ± 4.7 % were CD69+, and of FOXP3+ DN cells only 13.7 % ± 
6.3 %, indicating that the FOXP3+ DN cells have not received TCR-mediated signals. 
Similarly, the expression of CD5 was analyzed to study the maturational stage of DN 
cells. Expression of CD5 has been reported to correlate with the strength of TCR-
mediated signals in thymocytes (Azzam et al. 1998). We found differing expression 
levels of CD5, MFI of CD5 was 32 ± 20 in the FOXP3+ CD4+ SP cells, and only 3 ± 1 
in the FOXP3+ DN cells. 
We tried to isolate FOXP3+ DN thymocytes indirectly by depleting other cells 
in the absence of suitable surface markers. After depletion the average frequency of 
FOXP3+ DN cells was 38.6 % (range 10.3 % - 80.2 %). However, when the sorted 
cells were co-cultured with autologous CD4+ SP thymocytes or PBMC, no 
suppressive effect or IL-10 production was observed. The incapability to sort out 
viable FOXP3+ cells also prevented cell cultures and differentiation assays, and it was 
thus not possible to track the developmental role of the FOXP3+ DN thymocytes.  
 
 
2 FoxP3 expression in DP cells (II) 
2.1 CD25+ DP thymocytes express as much FOXP3 as CD25+ CD4+ SP thymocytes 
During the thymic T cell development the DN thymocytes mature to DP cells. 
Similarly to the DN thymocytes, the immature DP population, which accounts for 70-
90 % of all thymocytes (Spits 2002), already has a noticeable expression of FOXP3. 
The level of FOXP3 mRNA in DP cells mimics the FOXP3 level of thymocytes in 
general. Yet, a small population, 0.7 ± 0.6 % (0.1-1.7 %), of the DP thymocytes 
expressing also CD25 had a high expression of FOXP3 mRNA. The level of FOXP3 
mRNA in the CD25+ DP thymocytes was virtually equivalent to the isolated 
CD4+CD25+ SP thymocytes, which are considered functionally mature Treg cells 
(Stephens et al. 2001, Liotta et al. 2005, Annunziato et al. 2002, Cupedo et al. 2005, 
Wing et al. 2005). By comparison, FOXP3 mRNA was expressed at a low level in the 
CD4+CD25- SP thymocyte population.  
Flow cytometric analysis established that CD25 expression was strongly 
associated with FOXP3 in both the DP and CD4+ SP thymocytes, arguing for the use 
of CD25 as a substitute for the isolation of FOXP3+ cells. Nonetheless, a clear subset 
of CD25-FOXP3+ cells could also be detected in both the CD4+ SP and DP 
populations. That the FOXP3 protein levels, analyzed regardless of CD25 expression, 
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 were similar in DP and CD4+ SP cells (MFI 57  16 and 62  18, respectively, 
difference not statistically significant) is noteworthy.  
 
 
 
 
Figure 7. FOXP3 expression in thymocytes of different developmental stages.  
 
Four-color flow cytometric analysis of surface CD25 and intracellular FOXP3 protein. The 
frequency of FOXP3+ thymocytes in indicated gates is shown. Note that FOXP3+ DN cells 
are mainly CD25-and that in CD8+FOXP3+ cells the CD25 expression is low or absent. 
 
2.2 Markers of positive selection on FOXP3+ DP thymocytes 
To test whether the FOXP3+ DP thymocytes have already been positively selected, we 
determined their TCR expression level. As shown in the original article I, high levels 
of  TCR were expressed by the majority of CD4+ SP thymocytes, whereas the DP 
thymocytes contained large populations of TCR- and TCRlow cells as well. However, 
the FOXP3+ fraction of DP thymocytes already expressed high TCR levels, 
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 comparable to that of the FOXP3+ CD4+ SP thymocytes. Similarly to the FOXP3+ DN 
thymocytes, both FOXP3+ DP and FOXP3+ CD4+ SP cells expressed CD127 at 
clearly lower levels than the FOXP3- thymocytes. Lastly, the FOXP3+ DP thymocytes 
expressed CD69, while the majority of FOXP3- DP thymocytes were still CD69-. The 
majority of the CD4+ SP thymocytes, both FOXP3+ and FOXP3-, was CD69+. Thus 
the FOXP3+ DP subset clearly differed from the majority of the DP thymocytes 
having a phenotype of already positively selected cells. 
 
2.3 FOXP3+ DP thymocytes have features of immature cells 
Similar FoxP3+ thymocyte subsets have been described in mice, but the 
developmental relationship of these thymocyte populations remains uncertain 
(Fontenot et al. 2005, Wan and Flavell 2005, Fontenot et al. 2005, Pacholczyk et al. 
2006). Notably, it has been argued that the FOXP3+ CD25+DP thymocytes are not 
precursors of the more mature FOXP3+ CD4+CD25+ SP Treg cells (Fontenot et al. 
2005).  
To further study the developmental stage of the FOXP3+ DP thymocytes the 
CD5 expression was reviewed. CD4+ SP thymocytes, both FOXP3+ and FOXP3-, had 
a high expression of CD5. The FOXP3+ DP cells had higher expression of CD5 than 
the other DP thymocytes, but the level was significantly lower in comparison with the 
CD4+ SP subsets.  
Subsequently, we quantified the expression of RAG-2 mRNA in the thymic 
subsets. As an indicator of ongoing recombination activity in the  loci (Spits 2002), 
the RAG-2 mRNA levels were high in the DP cells. The CD25+ DP cells also 
expressed high levels of RAG-2. No significant difference was detected between them 
and other DP thymocytes. Some RAG-2 was expressed by both CD4+CD25+ and 
CD4+CD25- SP thymocytes, but the levels were significantly lower than in the DP 
populations.  
 
2.4 TCR repertoires of CD25+ DP and CD4+CD25+ SP cells 
We determined the TCR  chain repertoire of the CD25+DP, CD4+CD25+ SP and 
CD4+CD25- SP populations for comparison of the thymocyte subsets expressing 
FOXP3. (For a detailed description of the method, see original article II.) Most V 
genes displayed a polyclonal pattern in all three thymocyte subsets, as previously 
reported (Kasow et al. 2004). Numerous similarities were discovered between the 
CD25+DP and CD4+CD25+ SP thymocytes, but there were even more differences. In 
many instances, the repertoire of the CD25+DP cells was actually closer to that of the 
CD4+CD25- SP thymocytes. An additional quantitative comparison of the CD25+DP 
cells with CD4+CD25+ SP cells was made, but no evident congruity was observed. 
(Detailed description in the original article II.)  
In addition, we studied whether the frequency of the FOXP3+ DP thymocytes 
predicted the frequency of FOXP3+ cells in the CD4+ SP subset, as might be expected 
if the FOXP3+ DP cells are on the brink of maturing into SP cells. No correlation was 
observed. To summarize, these data imply that the FOXP3+ DP thymocytes have been 
positively selected but are still immature, in that they still express molecules 
associated with TCR rearrangements. 
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 2.5 FOXP3 expression in CD8+ SP thymocytes  
Also the CD8+CD25+ SP thymocytes have been reported to express FOXP3 mRNA 
and to have suppressive capabilities (Cosmi et al. 2003). Contrary to earlier data, the 
FOXP3 mRNA level in the CD8+CD25+ SP subset was significantly lower than in the 
CD25+DP or CD4+CD25+ SP thymocytes (P < 0.05 in both cases), but still higher 
than in CD8+CD25- thymocytes. Intracellular detection of FOXP3 protein showed that 
3.3  1.4 % of the CD8+ SP thymocytes expressed FOXP3. Flow cytometry 
confirmed that the CD8+ SP thymocytes expressed significantly less FOXP3 than 
either the DP or CD4+ SP thymocytes (MFI 47  10, P < 0.005 when compared with 
either of the two other subsets). Also the level of CD25 was clearly lower in the 
FOXP3+CD8+ SP thymocytes than either in the DP or CD4+ SP thymocytes, 
corresponding to a previous report (Cosmi et al. 2003). 
 
 
3 Dual-Specificity of Treg cells (III) 
3.1 Increased TCR C mRNA levels in CD4+CD25+ SP thymocytes  
When normalizing the PCR data to the TCR C gene, we noted that the CD4+CD25+ 
SP thymocytes consistently expressed more C mRNA than the CD4+CD25- SP 
subset. The immature DP cells also expressed higher levels of TCR C mRNA when 
compared to the CD4+CD25-cells. To double-check the results, we reanalyzed the 
samples using GAPDH for normalization in substitute for -actin, which was used 
initially. The results remained unchanged. By flow cytometry, we measured if the 
higher C mRNA levels reflected an increased expression of the  TCR proteins on 
the surface of individual cells. In contrast to the quantitative PCR results, the 
CD4+CD25- subset had the highest intensity of TCR, CD4+CD25+ cells expressing 
significantly less TCR proteins (MFI 71 ± 5 and 52 ± 6, P=0.0024), nonetheless more 
than the DP cells (24 ± 2).  
Since the  mAb we used reacts only with the whole TCR, we next 
analyzed the thymocyte subsets using a V12 mAb. We also permeabilized the cells 
in order to detect intracellular TCR  protein uncoupled to TCR  and CD3. The 
MFIs of CD4+CD25+ and CD4+CD25- cells were equivalent to the results obtained 
with the anti-TCR mAb. Thus, the differences of TCR expression levels did not 
explain our results of increased levels of TCR mRNA in CD4+CD8-CD25+ 
thymocytes.  
 
3.2 Expression of two different TCR V genes in CD4+CD25+ thymocytes  
The above results, along with the fact that the TCR  locus lacks allelic exclusion, 
suggested that the CD4+CD25+thymocytes might transcribe both TCR  loci 
simultaneously (Padovan et al. 1993). The CD4+CD25+subset had a higher frequency 
of V12+ than the CD4+CD25- subset, as would be expected if the CD4+CD25+subset 
included more cells expressing two TCRs. Similar results were obtained when using 
another V gene, V2. We then isolated CD4+CD8- thymocytes and analyzed the 
frequency of CD4+CD25+ and CD4+CD25- cells expressing both V2 and V12 
chains. Expression of two TCRs was significantly more common among the 
CD4+CD25+ cells. Similarly, isolation and subsequent analysis of V2+ thymocytes 
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 showed that the frequency of cells simultaneously expressing V12 was again 
significantly higher in the CD4+CD25+ thymocytes.  
 
3.3 Dual-specific cells express more FOXP3 
Next we wanted to define whether the mature Treg cells maintained the expression of 
two TCRs. CD4+CD25- and CD4+CD25+ cells isolated from blood had no significant 
difference in the TCR C mRNA levels. In the thymus, the CD25 intensity varied. 
However, in the periphery the T cells up-regulate CD25 also upon activation, and 
when studying PBLs, only CD4+ cells expressing high levels of CD25 are considered 
to be Treg cells (Baecher-Allan et al. 2001). In direct analysis of cells expressing 
simultaneously both V2 and V12, the dual-specific cells were more common in the 
CD4+CD25high subset than in the CD4+CD25- subset. Because the V2+V12+ 
population is so small, we subsequently isolated the V2+ PBL population. The 
prevalence of V2+ cells also expressing V12 was on the average four times higher 
in the CD4+CD25high population compared to the CD4+CD25- population. When 
measuring the frequency of the TCR V2+ and V12+ cells in the CD4+CD25high and 
CD4+CD25- subsets, the frequency of the V+ cells was significantly higher in the 
CD4+CD25high subset, invariably.  
To make certain that the dual-specific CD4+CD25high cells were Treg cells 
instead of activated T cells, we analyzed the FOXP3 expression in cells bearing one 
or two TCRs. Sorted cells expressing both V2 and V12 were compared with CD4+ 
cells or cells expressing either V2 or V12 alone. Significantly more FOXP3 
mRNA was detected in cells expressing two surface TCRs than in the control 
populations. An intracellular staining with anti-FOXP3 mAb attested these results. 
FOXP3+ cells were significantly more common among cells with two TCRs than 
among cells with a single TCR or the whole CD4+ population. Similarly, purified 
V2+ cells, expressing also V12 were significantly more frequent in the 
CD4+FOXP3+ subset than in the CD4+FOXP3- subset (1.5 ± 0.5 vs 0.7 ± 0.4, 
P=0.0149). These data affirm that the dual-specific cells are highly enriched in human 
CD4+CD25high FOXP3+ Treg cell population. 
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Figure 8. FOXP3 expression in dual-specific peripheral T cells. 
 
A, FOXP3+ cells are significantly more common among dual-specific T cells than among 
cells with one TCR or the whole CD4+ population. *** = P < 0.001. B, Isolated V2+ cells 
expressing also a second V, V12, were substantially more common among the 
CD4+FOXP3+ cells (R2) than in the CD4+FOXP3- subset (R1). The purity of the V2+ 
population was 99.0 %. 
 
3.4 V2 and V12 are comparable with the whole repertoire 
In our donors, V2 or V12 represented only 5-7 % of the whole repertoire. Hence 
detailed analysis was required to ascertain that these V chains are representative of 
the TCR  repertoire. Flow cytometric analysis showed that the V12+ cells were 
more common among CD8+ cells, while V2+ were equally represented within the 
CD4+ and CD8+ subsets. The frequency and intensity of the CD25 expression as well 
as the CD45RO expression was similar in V12+ and V2+ cells to that of cells 
expressing other V genes within the CD4+ population. The amount of FOXP3 
mRNA and protein was comparable in V2+ cells and all T cells. V12+ cells had a 
somewhat lower level of expression, probably due to the preference for CD8. Isolated 
V2+ CD4+CD25high and V12+ CD4+CD25high cells expressed as much FOXP3 as 
the CD4+CD25high cells in general. In addition, isolated CD4+CD25high cells 
expressing V2, V12, or both suppressed stimulated T cells as efficiently as the 
CD4+CD25high cells generally. The TCR repertoire analysis of V2+ and V12+ cells 
showed similar polyclonal profiles as other V chains. The TCR  repertoire of 
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 isolated V2+ or V12+ cells essentially resembled the repertoire profiles of other T 
cells as well. Except for the biased MHC class I recognition by the V12+ subset, 
V2 or V12 expressing cells do not differ from T cells expressing other V genes. 
 
3.5 Most human Treg cells express two functional TCR  chains 
Because only a few V-specific antibodies are available and a small number of cells 
can be examined, the evaluation of cells expressing two TCRs is troublesome. 
However, the produced calculations of the frequency of dual-specific cells, made 
using three complementary methods, were in close agreement (see description in 
original article III). Approximately 20 % of the CD4+CD25- population, comparable 
to T cells in general, was dual-specific. Frequency of cells with two TCRs in the 
CD4+CD25high subset ranged from 50 % to 99 %. These calculations firmly indicate 
that the majority of human CD4+CD25high Treg cells are dual-specific. 
Finally we wanted to test whether both of the TCRs on the surface of the dual-
specific Treg cells were functional. We studied the down-regulation of the surface 
TCR in V2+ single- and V2+V12+ dual-specific cells when bound by a ligand, 
V2 mAb. The MFI of the TCR, in cells expressing only V2, was reduced to 64 % 
of the original in CD4+ cells and to 65 % in the CD4+CD25high cells, while the 
intensity of the non-engaged V12, used as a negative control, remained stable (94 % 
in both cases). Dual-specific T cells gave similar results, and so did experiments 
carried out using V12 mAb as ligand. Dual-specific CD4+CD25high Treg cells seem 
to transmit TCR-mediated signals as competently as single-specific T cells. 
 
 
4 Treg cells in APECED (IV) 
4.1 Impaired function of Treg cells  
AIRE is an important regulator of the thymic T cell development (Mathis and Benoist 
2009), thus we wanted to study if the AIRE-mutation has an effect on the 
development of Treg cells in humans. No differences were detected in the frequency 
or intensity of CD4+CD25high cells when comparing APECED patients and controls, 
hence we studied whether the CD4+CD25high Treg cells of the patients were 
functioning properly. Polyclonal stimulation with anti-CD3 mAb or PHA resulted in 
equal proliferation of unfractionated cells in both groups. Co-culture of CD4+CD25high 
cells and polyclonally stimulated CD4+CD25- cells, (at ratios of 1:3 or 1:1) resulted in 
normal suppression of proliferation in controls, while the CD4+CD25high cells from 
patients failed to significantly suppress the response of CD4+CD25- cells. At the same 
time, an antigen-specific stimulation using Candida albicans evoked suppression by 
CD4+CD25high cells in both groups. This observation demonstrated that T cells from 
the APECED patients respond competently to suppression. This was also confirmed 
by an experiment where isolated CD4+CD25high Treg cells from healthy blood donors 
were cultured together with T cells from APECED patients or controls (at a ratio of 
1:1). Treg cells were able to suppress anti-CD3-induced proliferation equally in 
patients and controls (a decrease of 79.5 ± 12.2 % and 73.8 ± 23.2 %, respectively).  
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 4.2 Activation profile of Treg cells  
When comparing the activation status of the CD3+ cells of the patients and controls, 
no significant differences were detected in the expression of HLA-DR or CD62L. 
When expression of CD45RO was checked in addition to the aforementioned 
markers, no major differences in the CD4+CD25high populations between the patients 
and controls were observed. As described above, the patients and controls had a 
similar response to C. albicans. Because the patients are suffering from chronic 
candidiasis, we contemplated that the CD4+CD25high population in the patients might 
be enriched by a significant fraction of activated effector T cells. In that case, a result 
of the depletion of the CD4+CD25high cells would be a decreased response to Candida. 
However no decrease of the response was observed, nor did the depletion of the 
CD4+CD25high cells have any significant effect on polyclonal, anti-CD3-induced 
responses.  
Lastly, we determined the TREC level of PBL from patients and controls. 
There was considerable variation in both groups, but no clear differences were 
observed in the TREC content between the patients and controls, suggesting a similar 
proliferation history in the periphery. 
 
 
4.3 FOXP3 expression is diminished  
When quantifying the FOXP3 mRNA from PBMC, the level was double in the 
controls compared with the patients. Next we sorted the CD4+CD25high cells and, as 
expected, the sorted cells expressed FOXP3 mRNA at a much higher level than the 
total PBMCs in both patients and controls. The CD4+CD25high cells from the patients, 
however, expressed approximately four times less FOXP3 than the CD4+CD25high 
cells from the controls. In conclusion, the expression of FOXP3 mRNA was 
congruently lower in patients, both in the CD4+CD25high subset and in the total T cell 
population.  
Intracellular staining of FOXP3 protein showed that the frequency of FOXP3+ 
cells in the patients was significantly lower than in the controls, although the 
percentage varied and overlapped. Additionally, the MFI of FOXP3 was reduced in 
cells of the patients when compared with the controls.  
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Figure 9. Expression of FOXP3 in APECED patients and controls. 
 
A, Flow cytometric analysis of surface CD25 and intracellular FOXP3 protein. Patients 
expressed FOXP3 with decreased intensity: MFI of patient 1, 12 and of patient 2, 16 when 
compared with the controls: MFI of control 1, 31 and of control 2, 38. 
The percentages indicate frequency of FOXP3+ in gated CD4+ cells.  
B, Relative expression of FOXP3 mRNA in CD25high cells. The mRNA levels were 
determined by quantitative PCR and are shown on a relative scale as mean (range). 
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4.4 TCR repertoire of Treg cells  
Next we performed a TCR  chain repertoire analysis of the CD4+CD25high cells. 
Since the HLA type can influence the TCR V gene usage, we looked for and found a 
patient-control pair matching each other at the HLA class II locus. We then sorted the 
same number of CD4+CD25high cells from the patient and the control. The samples 
were also adjusted by quantitative -actin amplification. Although the sample size 
was just 50 000 sorted cells, the repertoire of the Treg cells was polyclonal and 
included most Vgenes. However, patient–control comparison showed significant 
differences in the TCR diversity. The repertoire of the control showed clonal 
expansions in most V genes. In the patient the repertoire was much less skewed and 
the average number of different CDR3 lengths within individual V genes was 
significantly higher. Additionally, compared to the average repertoire derived from 11 
cord blood samples, the repertoire of the APECED patient was significantly closer to 
that of the naïve repertoire than the repertoire of the control. Analysis of 4 HLA-non-
matched patient-control pairs supported the results. These results indicate that, in 
APECED patients, there might be a failure in the selection of the TCR repertoire of 
the Treg cells. 
 
4.5 AIRE localization in human thymus 
As Hassall’s corpuscles are reported to take part in the positive selection of human 
Treg cells (Watanabe et al. 2005), we investigated the relationship of AIRE+ cells and 
Hassall’s corpuscles in the human thymus. Immunohistochemical techniques 
demonstrated that the corpuscles were mostly AIRE-. The AIRE+ cells were dispersed 
within the thymic medulla and more abundantly at the margins of Hassall’s 
corpuscles. (For detailed description see original article IV). Thus the PTAs 
controlled by AIRE at this location may contribute to the Treg cell selection, and the 
lack of AIRE function may affect the observed defect in the Treg cells of APECED 
patients respectively. 
The role of Hassall’s corpuscles in T cell development remains puzzling. They are 
well developed in human thymus, but interestingly in mice these structures are poorly 
represented (Farr et al. 2002). We analyzed FoxP3 mRNA levels to define if there is a 
failure of the Treg cell development in Aire-/-mice. No significant differences in either 
the thymus or the spleen were observed. In accordance with previous reports (Liston 
et al. 2003, Kuroda et al. 2005, Anderson et al. 2005), our data demonstrate that in 
Aire-/- mice, there is no evident Treg cell defect analogous to APECED patients. 
Consequently, there may be some mechanistic difference in the development of Tregs 
between mice and men. 
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 DISCUSSION 
 
1 Treg cells and transcription factor FOXP3 
1.1 FOXP3 as a marker for Treg cells 
This study mostly used FOXP3 as the surrogate marker in identifying Treg cells. 
Indeed, when the transcription factor FOXP3 was originally discovered, it was 
believed to be an exclusive, Treg lineage-determining molecule. The absence of Treg 
cells, responsible for the characteristic phenotype of the Scurfy-mouse and IPEX-
patients, was found to be due to a mutation in the transcription factor FOXP3 gene. 
Consequently it was thought that the expression of FOXP3 equals the Treg phenotype 
(Ziegler 2006, Khattri et al. 2003, Fontenot et al. 2003, Hori et al. 2003). This 
judgement has recently turned out to be inexact.  
The peripheral increase in FOXP3 expression seems to be common 
phenomenon in humans and it may be constant or transient (Walker et al. 2005, 
Walker et al. 2003, Yagi et al. 2004). Of note is that FOXP3 expression does not in all 
circumstances mean gain of suppressive capacity (Wang et al. 2007, Allan et al. 2005, 
Gavin et al. 2006). Besides the up-regulation of FOXP3, the expression must be 
maintained in order to obtain the Treg characteristics. The amount of FOXP3 
expression has been reported to vary, and only high and continuous expression 
confers with the regulatory phenotype (Allan et al. 2008). It has been proposed that 
transient, activation-induced FOXP3 expression might be a mechanism to attenuate 
the activation or dampen the response of these cells.  
Although FOXP3 is recognized as a characteristic of CD4+ T lymphocytes, 
there are also studies suggesting that FOXP3 is expressed in epithelial cells, among 
others in the thymus, lungs and mammary glands (Chen et al. 2008). Two recent 
reports demonstrated that FOXP3 acts as a breast cancer suppressor gene, repressing 
the oncogenes ErbB2/HER-2 and SKP2 and suppressing tumor growth (Zuo et al. 
2007b, Zuo et al. 2007a). A mutation of FoxP3 in the thymic stroma has also been 
demonstrated to lead to defective thymopoiesis (Chang et al. 2005). However, 
controversy, particularly concerning the expression of FOXP3 in thymic epithelium, 
remains (Liston et al. 2007). 
 At the moment the transcription factor FOXP3 is considered as a 
characteristic, but not a unique, marker of the Treg cells. Although its role in the 
development of natural Treg cells has become ambiguous, its impact on the functions 
of these cells is beyond dispute. The continuous expression of FOXP3 contributes to 
the phenotype seen in Treg cells, for example the expression of CD25 and CTLA-4 
(Sakaguchi et al. 2008, Lopes et al. 2007). Our analyses of FOXP3 in the human 
thymus showed FOXP3 expression at different developmental stages of T cells. 
FOXP3 is especially suited for the identification of Treg precursors in the thymus.  
 
1.2 Factors affecting the up-regulation of FOXP3 
Knowledge of the factors or molecules triggering the up-regulation of FOXP3 during 
thymic development is incomplete, but the dominant view is that TCR signaling is 
essential (Fontenot et al. 2005), although supplementary signaling is also required 
(Burchill et al. 2008, Lio and Hsieh 2008). Our results, however, show that in the 
 61
 human thymus there clearly is a population of immature DN thymocytes that already 
express FOXP3, yet mostly in the absence of TCR. Additionally, these cells share the 
expression of some characteristic Treg cell markers with their more mature thymic 
CD4+CD25+ counterparts. The FOXP3 expression level is also similar to the FOXP3+ 
CD4+ SP cells. These results dispute the necessity of TCR signaling in the induction 
of FOXP3.  
Indeed, increasing evidence has given support to the possibility of pre-Treg 
cell existence prior to the thymic selections. It is also suggested that Treg cell 
development is initiated already at DN stage in mice. According to this theory, the DP 
thymocytes interact with DN cells before the recombination of the TCR genes. A 
subset of cells that are not exposed to this ‘trans-conditioning’ are more disposed to 
mature to Treg cells later on during development (Pennington et al. 2006). 
Furthermore, some recent studies have demonstrated that the induction of the genetic 
program of Treg cells may be an early event, preceding the FOXP3 up-regulation. 
The cells that were destined to develop into Treg cells but lacking a functional 
FOXP3 protein, acquired several Treg characteristics excluding regulatory properties 
(Lin et al. 2007, Gavin et al. 2006).  
In a recent report it appeared that the expression of transgenic Treg-TCR did 
not enhance Treg development (DiPaolo and Shevach 2009). Although the lack of 
increased induction of Treg cells may be due to some factor in this transgenic setting, 
it may also suggest that Tregs are not, indeed, induced simply by the signals received 
through a self-reactive TCR, but instead have to be pre-committed to the lineage 
already earlier during the development in order to survive through the selection 
bearing such autoreactive receptors. 
 Thus it appears that, presumably, there are other factors affecting the 
commitment to Treg lineage already in the early stages of development independently 
of TCR. This view is supported by our results, as we see FOXP3 already in DN 
human thymocytes. The commitment to the Treg lineage and/or initial up-regulation 
of FOXP3 in the DN thymocytes may thus be induced by cytokines or signals derived 
from some thymic cell population if not all stochastic.  
 
 
2 Thymic development of natural regulatory T cells 
2.1 Relationships of FOXP3+ precursors 
If FOXP3 is up-regulated already in the DN thymocytes, then one may suggest that 
the differentiation of Treg cells progresses through the DP stage to mature SP Treg 
cells. Conflicting views have however been presented. Although a few DP 
thymocytes already express FoxP3 in mice as well, these cells are not considered 
precursors of more mature FoxP3+ CD4SP cells. Instead the favored hypothesis is that 
lineage commitment to Treg cells occurs in SP thymocytes (Fontenot et al. 2005). 
However, recent studies, also in mice, have suggested that the Treg lineage 
commitment takes place already in the thymic cortex or during positive selection 
(Liston et al. 2008, Cabarrocas et al. 2006).  
The first selection step after the TCR rearrangements is the positive selection, 
confirming recognition and restriction to self-MHC molecules. CD5 expression, 
correlating with the strength of TCR-signaling (Azzam et al. 1998) was scant on the 
FOXP3+ DN cells. Furthermore, the expression of CD69, a marker associated with 
TCR-mediated signaling and positive selection (Hare et al. 1999), was low on 
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 FOXP3+ DN cells as expected if under one third of those cells expressed TCR. A 
fraction of the developmentally more mature DP thymocytes examined, contained 
FOXP3 at levels comparable to CD4+CD25+ thymocytes, and also expressed CD25. 
The association of CD25 expression with FOXP3 was pronounced in the DP and 
CD4+ SP thymocytes. CD25 was expressed by the majority, but not all FOXP3+ cells. 
There was also a clear subset of CD25- FOXP3+ thymocytes. Of the FOXP3+ DN 
cells less than one-fourth expressed CD25. Thus, the CD25 expression in thymocytes 
seems to be associated with signal transduction through TCR. In fact, a two-step 
model of Treg development in mice also suggests that CD25 up-regulation is induced 
after the recognition of self–antigens (Lio and Hsieh 2008).  
In contrast to the FOXP3+ DN cells, FOXP3+ DP cells were CD69+ and 
TCRhigh and most likely already positively selected. Consistent with our results it has 
been reported that in humans the CD25hi DP thymocytes detected were CD69+ 
suggesting that the commitment to the regulatory lineage occurs during positive 
selection (Darrasse-Jeze et al. 2005).  
Nevertheless, our results showed that the CD25+ DP thymocytes were still 
immature. They expressed CD5 more than the other DP cells, but less than mature SP 
cells. Secondly the DP FOXP3+ thymocytes still expressed high levels of RAG-2, 
indicating immaturity and potential to improve their TCR (Spits 2002)  
  To define the developmental relationship between the CD25+ DP and 
CD4+CD25+ SP thymocytes, a comparison of the TCR repertoires of these 
populations was made. Regardless of the phenotypic similarities of FOXP3+ DP and 
mature FOXP3+CD4+CD25+ thymocytes, there was a clear disparity of repertoires 
between these two populations. There are several possibilities to explain these 
repertoire differences. If FOXP3+ DP and SP cells represent a continuous 
developmental lineage, possibly not all of the FOXP3+ DP cells mature into SP cells. 
Some of the FOXP3+ DP cells may still be deleted during selection. Up-regulation of 
FOXP3 in itself does not appear to provide protection from deletion (Hsieh et al. 
2006), although there are also conflicting results. Additionally, part of the DP cells 
may still undergo rearrangements of the TCR  chains, thus altering the repertoire. 
FOXP3+ DP cells indeed still express RAG-2, enabling modifications of  chains. On 
the other hand, some thymocytes might up-regulate FOXP3 only after entering the SP 
stage, in which case these TCRs are missing from the FOXP3+ DP repertoire. Perhaps 
there is also down-regulation of FOXP3 expression during the development in the 
absence of some critical signals demanded for maintenance of permanent FOXP3 
expression. This could explain some of the inconsistencies we see in the TCR 
repertoires. In addition, some of the FOXP3+ DP cells may differentiate into CD8+ 
FOXP3+ SP cells (Cosmi et al. 2003), accounting for part of the differences in the 
repertoires.  
Our results demonstrate that FOXP3 is expressed in all developmental stages 
of T cell development. Consequently these results are suggestive of a linear 
developmental pathway for Treg cells. Thus one can propose that the development of 
Treg cells and other T cells is presumably broadly similar, DN cells evolving into DP 
cells and maturing through selection steps to CD4+ and CD8+ SP cells. There was an 
increasing gradient of CD5 intensity, demonstrating that the developing FOXP3+ cells 
get increasing amounts of TCR-mediated signals as they mature.  
However, there was no correlation in numbers between FOXP3+ DN, DP and 
SP cells. Up-regulation of FOXP3 is probably not the final definitive point in the Treg 
cell lineage commitment. Thus not all thymocytes that up-regulate FOXP3 mature 
into Treg cells and proceed to the periphery. Since the FOXP3+ DP cells still show 
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 signs of immaturity one can suggest that the final commitment occurs probably not 
until during the SP stage and the negative selection. 
In addition, to the linear developmental pathway, up-regulation of FOXP3 might 
occur at every stage along the developmental pathway, since the FOXP3+ cells are 
represented in all developmental stages.  
 
2.2 CD8+ T cells expressing FOXP3 
Our data, as well as other recent publications have shown that there is clearly FOXP3 
expression in the CD8+ SP thymocyte population (Cosmi et al. 2003, Fontenot et al. 
2005). These cells also have intermediate expression of CD25 (Cosmi et al. 2003, 
Cupedo et al. 2005). However, in contrast to earlier reports our results showed that the 
FOXP3 expression level in CD8+ SP thymocytes was significantly lower than either 
in the CD4+ SP or DP thymocytes.  
In a recent report it was shown that the amount of FOXP3+CD8+ cells in 
peripheral blood is negligible, however a population of FOXP3+CD8+ cells in human 
tonsils was discovered (Siegmund et al. 2009). These cells had the Treg phenotype 
with the exception that they were predominantly CD25- or CD25low. FOXP3 
expression in CD8+ cells can be induced and maintained also in the periphery. These 
peripherally induced CD8+ FOXP3+cells are also capable of suppressing CD4+ cells. 
A recent study showed that in vitro induced CD8+CD25+ cells expressed 
approximately one-ninth of the FOXP3 level of CD4+CD25+ cells from the same 
culture (Bisikirska et al. 2005). The significance of FOXP3 expression in CD8+ cells 
is unclear and the meaning of the lower FOXP3 expression level is another 
peculiarity. 
As the high quantity of FOXP3 is so clearly considered a prerequisite for true 
Treg cells, it must be contemplated whether the FOXP3 expression in CD8+ cells is an 
indication of a regulatory population or rather just an activation-induced phenomenon. 
Distinct from CD8+ thymocytes, the FOXP3 expression seems to remain continuously 
high in DN, DP and CD4SP cells. Perhaps the low FOXP3 expression seen in the 
CD8+ thymocytes is a transient phenomenon similar to the activation-induced up-
regulation of FOXP3 in the periphery. Alternatively, the signals associated with MHC 
class I restriction and selection to the CD8+ lineage may be different, leading to a 
lower expression of FOXP3. On the other hand, our results demonstrated that FOXP3 
is up-regulated already before the CD4/CD8 lineage decision. Thus it may be that the 
CD8 lineage decision affects FOXP3 transcription, decreasing or halting it. 
 
2.3 Significance of TCR in Treg cell development 
In the light of our results, TCR is not a prerequisite for FOXP3 expression. However, 
it is important to note that our results do not refute a pivotal role of TCR in human 
Treg cell development. Our results show that the FOXP3+ DP and SP cells have 
already up-regulated CD5, CD25 and CD69 expression. This indicates that these cells 
have already received TCR-mediated signals. Although TCR is not necessarily 
important in the up-regulation of FOXP3, its affinity and specificity have inevitably 
great importance in the thymic selections and it defines the specificity and function of 
a Treg cell.  
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 2.4 Negative selection of Treg cells 
Treg cells are shown in many instances as self-specific (Apostolou et al. 2002, Hsieh 
et al. 2004, Romagnoli et al. 2002, Hsieh et al. 2006, Jordan et al. 2001, Cozzo et al. 
2005). If they, indeed, are self-specific how do they pass through the negative 
selection? In several studies it has been shown that the TCR signaling of Treg cells is 
defective. Cells are not unable to signal, but have altered their signaling properties, 
probably due to FOXP3 expression (Campbell and Ziegler 2007). Thus, if FOXP3 is 
up-regulated before the selection steps it could have a role in adjusting the strength of 
TCR-derived signaling during selection and help to avoid deletion. It is noteworthy to 
mention that although FOXP3 may render these cells more “stable”, it, without a 
doubt, does not prevent the possibility to negatively select these cells. 
 Another possibility to evade negative selection is suggested by the data of 
cells expressing two TCRs. The significance of dual-specific cells, if any, has been 
obscure, yet several reports have suggested an autoreactive role for dual-specific cells 
(Elliott and Altmann 1995, Sarukhan et al. 1998, Zal et al. 1996). When dual-specific 
T cells were first discovered, it was indeed thought that although bearing probably an 
autoreactive TCR, these cells could evade negative selection and be positively 
selected through the other receptor. The intracellular competition of two  chains for 
pairing with a single  chain decreases the surface expression of both TCRs, thus 
allowing the cell to down-modulate the autoreactive TCR and escape deletion (Zal et 
al. 1996).  
 
2.5 Treg cells express two different TCRs  
Our results clearly demonstrate that the number of dual TCR specific cells is greatly 
enriched among human Treg cells. As our data is based on the surface expression of 
two TCRs, both  chains are verifiably paired witha chain. Also, the TCR 
complexes of dual-specific Tregs were effectively internalized upon stimulation 
referring that both receptors are able to signal competently. We can not show that 
both receptors participate in the selection or the responses in the periphery, but in the 
light of our results we may assume that both TCRs of dual specific Tregs are 
functional. However, due to the availability of only a few V specific mAbs, the high 
frequency of dual-specific cells we suggest is based on estimates and the actual 
prevalence may differ, nonetheless the relative difference between Treg cells and 
other T cells should not be affected. 
Our data show that cells with two TCRs are significantly more common 
among CD25+ thymocytes already in the thymus and a high frequency of dual-
specific Treg cells is seen also in the periphery. This means that the commitment of 
the dual TCR specific Treg cells occurs in the thymus and dual-specificity possibly 
has a role in directing these cells to the regulatory lineage, probably during the 
intrathymic selection. Of course some dual-specific cells may also up-regulate 
FOXP3 in the periphery after activation similarly to the conventional T cells with 
single TCR specificity and thus complement in part the dual-specific Treg 
compartment. 
Some studies in mice have also reported a role for dual-specificity in the 
development of Treg cells. Conclusions have been made based on studies with 
transgenic mouse strains bearing an autoreactive TCR. It has been noted that Treg cell 
development is induced more efficiently in mouse models, where endogenous TCR 
rearrangements are possible. The presence of a secondary TCR indeed seems to 
provide an opportunity for the transgenic TCR to escape deletion and direct the 
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 developing thymocyte into the Treg cell lineage (Van de Keere and Tonegawa 1998, 
Itoh et al. 1999, Kawahata et al. 2002, Hori et al. 2002). Tregs predominantly express 
endogenous TCR  chains with a transgenic  chain, as endogenous  chains possibly 
contribute to the positive selection of thymocytes to Tregs. RAG-deficiency blocks 
gene arrangements in the endogenous TCR  locus and in general abrogates the 
development of Tregs in TCR transgenic mice (Itoh et al. 1999). This was true even 
when the transgenic TCR was derived from a Treg cell (DiPaolo and Shevach 2009). 
On the other hand, analyses of mice unable to express two different V chains have 
shown that Treg cells can develop and function normally even when dual-specificity 
is prevented (Suto et al. 2002). Thus in mice, Treg development may have different 
requirements and the expression of two TCRs is not an absolute prerequisite for Treg 
cell development. 
In conclusion, one explanation to the essential problem that how Treg 
precursors expressing autoreactive TCRs are not deleted, while other thymocytes with 
such TCRs are directly negatively selected, is offered by the existence of two TCR 
specificities. Our results imply that the presence of a second  chain could give dual-
specific thymocytes, not only a chance to be positively selected, but an advantage to 
diverge to the Treg cell lineage instead of negative selection. 
 
2.6 Consequences of dual-specificity on Treg cells 
The possibility of two different functional V chains in Treg cells diversifies the 
human repertoire in all likelihood. The repertoires of both the selected and the 
secondary receptors are likely versatile on the dual specific cells (Kasow et al. 2004). 
This is supported by our results since the isolated CD25+ V2 or V12 cells had 
polyclonal  and  chain repertoires. It has been demonstrated that the dual receptor 
T cells can extend the repertoire for foreign antigens in non-Treg cells. In a recent 
study the transgenic TCR could not be selected in the thymus, so only the co-
expression of a second TCR led to efficient intrathymic selection. These dual TCR 
cells were present at low frequencies in the naïve repertoire. However, when the non-
selected TCR responded to foreign antigens presented by the self-MHC, these cells 
dominated the antigenic response through clonal expansion (He et al. 2002). Thus 
dual TCR cells can widen the functional repertoire through the second receptor. 
Treg cell development has been reported to be dependent on the interaction 
with self-antigens in the thymus. However, other results have clearly shown that the 
Treg cells can respond to foreign antigens in the periphery. Several reports have 
shown Treg cells to have a role in infectious disease pathogenesis, for example in 
parasite or viral infections (Bluestone and Abbas 2003, Belkaid et al. 2006). Thus it 
seems plausible that natural Tregs have TCR specificities both for self and foreign. 
Our data offer a logical explanation for the discrepancy of Treg TCR specificities, 
where Treg cells can be selected through a self-specific TCR and the cells still 
recognize exogenous antigens through the other receptor. The repertoires of the dual-
specific cells may consequently include specificities to both self and foreign. 
Although at least part of the Treg cells may have been selected through the 
autoreactive TCR, in the periphery, activation of the dual cells may occur through 
either of the receptors and the effect depends on the antigen encountered. Activation 
through the self-specific receptor might prevent autoimmunity or promote tolerance, 
while recognition of a foreign antigen would elicit control of pathological immune 
response.  
 
 66
  
 
 
 
 
Figure 10. Selection of dual-specific T cells 
 
T cells expressing a TCR with high affinity to self antigens are deleted during the T cell 
development. Transgenic mouse models have shown that the expression of a second  chain 
can cause intracellular competition between the two  chains for pairing with the  chain. In 
addition, the two TCRs compete for the same intracellular signaling molecules. This may lead 
to down-regulation of an autoreactive TCR. Negative selection is avoided and the cell is 
positively selected through the other TCR to the Treg cell lineage. In the mature T cell the 
expression of the high affinity receptor is probably low but still sufficient to activate the cell. 
Alternatively the effect of the two TCRs could be synergistic. As a single TCR neither of the 
TCRs would be positively selected, but when signals are transmitted through both TCRs they 
promote selection. The fact that Treg cell population is enriched in cells expressing two TCRs 
suggests that dual specificity has an active role in directing cells to the Treg cell lineage. 
 
2.7 AIRE and Treg cells 
At least some of the self-antigens, important to thymic selection, are controlled by 
AIRE. However analysis of Treg cells in Aire -/- mice has shown them to develop and 
function normally (Liston et al. 2003, Kuroda et al. 2005, Anderson et al. 2005). It is 
possible that autoreactive T cells are held in check by the properly functioning Tregs 
in Aire -/- mice, thus keeping the clinical picture of these Aire knock-out mice mild.  
Our data show that in APECED patients the Treg cell population is impaired, 
thus in humans AIRE may contribute to the development of Treg cells. The function 
of Treg cells in APECED patients was defective and they had an impaired capacity to 
suppress polyclonal responses. In addition, the level of FOXP3 expression, both 
mRNA and protein, was significantly lower in APECED patients. These data are in 
good agreement with the results suggesting that the regulatory capabilities correlate 
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 directly with the level of FOXP3 expression (Allan et al. 2007, Wang et al. 2007).  
The primary cell type in the thymus expressing AIRE, and consequently 
PTAs, are mTECs (Björses et al. 1999, Heino et al. 1999). The variety of peripheral 
antigens governed by AIRE is probably also the source of antigens that are involved 
in the selection of Treg cells. A recent report in mice demonstrated that Aire+ mTECs 
can directly generate antigen-specific Treg cells (Aschenbrenner et al. 2007). Our data 
showed that AIRE+ mTECs are enriched around Hassall’s corpuscles in the thymic 
medulla. Hassall’s corpuscles secrete TSLP inducing maturation of DCs, which in 
turn support the Treg cell development in humans (Watanabe et al. 2005). It is 
possible that these medullary DCs collect mTEC-derived antigens from apoptotic 
AIRE+ cells surrounding them and thereafter induces differentiation of regulatory T 
cells specific to these AIRE-controlled PTAs.  
Interestingly, in mice, Hassall’s corpuscles are poorly developed (Farr et al. 
2002). Additionally it was recently reported that in Aire-deficient mice, there is nearly 
an absence of Hassall’s corpuscle-like structures in the medulla (Yano et al. 2008). 
Nonetheless, Treg cells in Aire-/- mice function normally. Thus it seems that there 
may be some mechanistic differences in the Treg cell development between mice and 
men. This may explain why mouse Treg cells are normal even in the absence of Aire. 
Nevertheless, the mechanism by which AIRE-deficiency leads to a defect in 
Tregs is unclear. One possibility is that due to the deficiency of functional AIRE, the 
loss of selecting antigens impairs the Treg cell development. Our results show 
differences in the Treg TCR repertoire between APECED patients and controls. TCR 
repertoires in patients were less skewed and resembled an average naïve repertoire 
more than that of the controls. This may result from defective selection of the Treg 
TCR repertoire. However, antigen-specific failure would be expected to appear as 
narrow holes in an otherwise normal repertoire and this evident difference in the 
clonal distribution evokes an impression of a broader perturbation. The naive-like 
TCR repertoire in APECED patients might also be due to defective Treg cell 
activation, reflecting diminished clonal expansion. The defective suppression by 
Tregs of APECED patients also infers that the perturbation is systemic and not 
restricted to AIRE-specific antigens. Indeed, compatible with our results, it has been 
reported that the antigen presentation might be disturbed more generally in AIRE-
deficiency, not just concerning antigens under control of the AIRE (Anderson et al. 
2005, Johnnidis et al. 2005).  
In a recent report it was demonstrated that there is AIRE-regulated antigen 
presentation also in the periphery, leading to the deletion of autorective T cells 
(Gardner et al. 2008). If such peripheral expression of AIRE exists also in humans, it 
is missing from APECED patients. Thymic development of Treg cells seems to be 
impaired in APECED patients. However, it is not known whether there are 
disturbances in the peripheral induction of Treg cells. 
In conclusion, our results suggest that a Treg cell defect is involved in the 
pathogenesis of APECED. In mice, Aire-deficiency does not lead to a defective 
function of Treg cells and Aire knock-out mice remain remarkably healthy. On the 
contrary in humans the AIRE-mutation causes a malfunction of the Treg cells and 
APECED patients suffer from various disease manifestations.  
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Figure 11. Hypothesis about the development of FOXP3+ regulatory T cells in the 
human thymus 
 
Our results show that FOXP3 is expressed already at the DN stage of the thymic T cell 
development and we suggest that Treg cells follow a linear developmental pathway, broadly 
similar to that of conventional T cells. Thus we conclude that the differentiation of Treg cells 
begins already at the DN stage and the cells mature through the DP stage to become CD4+ 
FOXP3+Treg cells. Treg cells and conventional T cells develop from common precursor cells 
and the original up-regulation of FOXP3 expression may be stochastic or induced by 
unknown signals in the thymic microenvironment. The immature FOXP3+ Treg precursors go 
through thymic selections and the final lineage commitment occurs during the selections. 
Moreover, conventional T cells may probably convert to the Treg lineage during their 
development.  
 A subset of CD8+FOXP3+ thymocytes also exists. Whether they diverge from 
FOXP3+ DP thymocytes or represent an independent subset which up-regulates FOXP3 upon 
additional signals is not known. 
AIRE contributes to the negative selection of conventional T cells. The clear defect in 
Treg cells of the APECED patients suggests that AIRE may also influence the development 
and/or selection of Treg cells in humans.  
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 CONCLUDING REMARKS 
 
 
The results of this thesis shed light on the development of Treg cells in humans and at 
the same time demonstrate differences between mice and men.  
My data support the view that the commitment to the Treg cell lineage in the 
thymus is an early event. My results demonstrate that there clearly is a population of 
DN thymocytes already expressing FOXP3 in the absence of TCR. This model of 
early commitment also alludes that up-regulation of FOXP3 is not dependent on 
TCR-mediated signals. In addition to FOXP3, these cells already share features of 
Treg cells with their more mature thymic CD4+CD25+ counterparts, which are 
considered functional Treg cells. A similar FOXP3+ population is also seen in the 
CD25+ DP thymocyte subset. These cells have already rearranged their TCR, however 
they still show signs of immaturity. Hence it may be concluded that the differentiation 
to Treg cells likely begins already during the DN stage, with the precursors evolving 
through the DP stage to become mature CD4+ Treg cells. Yet the final decision to 
mature to Treg cells depends on the TCR and occurs during selection.  
There is also clear enrichment of dual-specific cells among Treg cells in 
humans. My data demonstrate that the presence of a second TCR influences the fate 
of the dual-specific cell in a non-transgenic setting. That is, I suggest that dual-
specificity does play an active role in directing cells to the regulatory lineage. Treg 
cell specificities are unknown, yet preference for self has been suggested. The dual-
specificity of Treg cells offers an explanation firstly to the question of how cells 
bearing self-specific TCR can avoid negative selection and secondly, to the 
disagreement concerning the TCR repertoire of these cells. In addition, this is the first 
demonstration of dual-specificity having an influence on the normal immune system. 
  AIRE plays an essential role in the selection of T cells, as it contributes to the 
deletion of autoreactive T cells. My results of impaired function of Treg cells in 
APECED patients suggest that the absence of AIRE seems to disturb the development 
of Treg cells on some level as well. Both AIRE and Treg cells are central in the 
maintenance of immunological tolerance. Therefore, it seems natural that AIRE may 
influence the development of natural Treg cells in the thymus. The reduced function 
of Treg cells in APECED patients probably reflects the decreased expression of 
FOXP3. In addition the more naïve-like repertoire of Treg cells suggests altered 
selection and generation of Treg cells in the thymus and possibly also in the 
periphery. Contrary to humans, there is no recognized defect of Treg cells in Aire-
deficient mice and respectively the autoimmune manifestations of these mice are 
mild. Thus the comparison of mice and humans shows the significance of Treg cells 
in tolerance. 
Because of their therapeutic promise, Treg cells are currently the focus of 
intense investigation. However, before these hopes can be realized, Treg cell biology 
must be understood in sufficient detail. The results described in my thesis elucidate 
the developmental pathway of human Treg cells and their importance in autoimmune 
diseases. The results also provide the basis for an in-depth analysis of the early stages 
of Treg cell development and the significance of TCRs in lineage commitment. 
Detailed characterization of Treg cell defect in APECED patients will also clarify the 
role of AIRE gene in human Treg cell development. 
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